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ABSTRACT 
Is There a Difference in Weight Over Time In Heart Failure Patients  
Based on Cognitive Function? 
Janet Riggs MSN, RN, DrNP(c) 
Background and Objectives: Patients with heart failure (HF) have a high hospital 
readmission rate within 30 days of discharge due to dyspnea caused by water weight 
gain. Additionally, 22% of HF patients have cognitive impairment (CI) impacting their 
ability to engage in self-care activities. There is a paucity of research to measure the 
impact of cognitive function on change in weight over time. 
Design: This was an observational, longitudinal study of adult patients, with Class II-IV 
HF who were evaluated at time of discharge (T1) from a hospitalization for acute 
exacerbation of HF and at a clinic visit (T2) 4-8 weeks after discharge.  The participants 
completed a 30-point Montreal Cognitive Assessment (MoCA) Inventory tool, and were 
weighed at T1 and T2.  
Results: Twenty-one participants (mean age 67.1 ± 12.2, 76.2% male, 81% Caucasian) 
completed both visits. The MoCA cutoff for mild CI was 24, where 42.9% of this sample 
scored below 24 at baseline. The change in weight between T1 and T2 was not statistically 
different (M change 0.43, SD 9.64; 95% CI, - 4.08 to 4.94; p = .84). The Independent T 
test of a change in weight in those HF participants with and without CI was not 
statistically different (high MoCA score, M change in weight = 0.62, SD 11.22; low 
MOCA scores, M change in weight = 0.20, SD 7.94; t(df 18) = - 0.09, p = .93). The re-
hospitalization rate was 23.80% (n = 5). No cognitive assessment was documented in the 
medical record by healthcare professionals at time of hospital admission or at the clinic 
visit. 
x 
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Conclusion: Findings demonstrated there was no statistically significant difference in 
change in weight over time when participants were divided into low or high scores on the 
MoCA.  The hospital readmission rate for HF was similar to that reported in other 
studies. This study found that assessments of cognitive function in HF are not being 
documented in the medical record. This study lays the groundwork for a larger study of 
the impact of CI on change in weight over time.  
 Key Words: cognitive impairment, heart failure, daily weights   
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Chapter 1: Introduction and Overview 
Introduction 
Heart failure (HF) is a progressively deteriorating syndrome in which the 
pumping action of the heart is unable to deliver sufficient blood to the cells of the body to 
meet their needs for oxygen metabolism (Maliakkal & Sun, 2014; Yancy et al., 2013) 
leading to exercise intolerance (Parrinello, Torres, Paterna, di Pasquale, Licata, 2008). 
HF is further characterized by fluid retention, fatigue, and difficulty breathing which 
interfere with a person’s ability to carry on their usual activities of daily living (Aliti, 
Ragelo, Clausell, Rohde, Biolo, & Beck-da-Silva, 2013; Jessup et al., 2009; Linhares, 
Aliti, Castro, & Rabelo, 2010; Parrinello et al., 2008). Fluid accumulation and overload 
are the main causes of cardiac decompensation, pulmonary congestion, and 
hospitalization (Desai & Stevenson, 2012; Parrinello et al., 2008).  
HF is increasing in incidence every decade due to improved survival of the 
chronic condition itself, and also advances in treatment of contributing conditions (e. g. 
myocardial infarctions, abnormal cardiac valve function, and hypertension) (Heidenreich 
et al., 2013; Herr et al., 2014). Untreated or under treated hypertension is responsible for 
most cases of diastolic HF (HFpEF), while injury to the left ventricle is responsible for 
most cases of systolic HF (HFrEF) (Gheorghiade, Vaduganathan, Fonarow, & Bonow, 
2013; Yancy et al., 2013). The significance of this this improved survival is there will be 
an increase in adults with HF over the next two decades who will require frequent 
hospitalizations and close follow-up in the home environment (Shah, Rahim, & Boxer, 
2013). 
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One reason for this increase in hospital admissions, apart from the sheer increase 
in numbers of people living with HF, is the complex nature of the treatment 
(Gheorghiade, Shah, et al., 2013;., 2013; Linhares et al., 2010; Shah et al., 2013). It is 
difficult for patients to manage the multiple therapies required to treat HF resulting in 
missed medications, drinking too much fluid, and failing to monitor their weight on a 
daily basis (Lee et al., 2013; Linhares et al., 2010). Failure to adhere to these therapy 
regimens results in worsening function of the heart muscle, leading to an increase in 
hospital re-admissions and mortality (Desai & Stevenson, 2012; Linhares et al., 2010; 
Mockler, et al., 2009; Parrinello et al., 2008; Shah, et al., 2013).  
Management of HF is multifactorial and complex. One of the cornerstones of 
therapy is to attempt to manage the intricate relationship between excess sodium and 
fluid intake by patients (d'Almeida, et al., 2014). In HF, the renin-angiotensin-aldosterone 
system (RAAS), along with other neurohormones, is activated and stimulates the thirst 
center (Allida, et al., 2014; Lee and Tkacs, 2008; Waldreus, van der Wal, Hahn, van 
Veldhuisen, and Jaarsma, 2014). Activation of the RAAS causes the body to retain 
sodium which results in water retention (Bock and Gottlieb, 2010; Palazzuoli, et al., 
2014) and can lead to pulmonary congestion (Kemp and Conte, 2012). Additionally, it 
has been recently shown that increased salt intake was correlated with elevated high-
sensitivity C-reactive protein (Hs-CRP) levels, suggesting that salt may also contribute to 
inflammatory damage in HF (Azak, et al., 2014).   
The thirst precipitated by these neurohormonal changes is persistent and 
debilitating, making it almost impossible to find relief of this symptom using non-
pharmacological therapies such as synthetic saliva (Allida, et al., 2014; Waldreus, et al., 
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2014). As a result, HF patients may not be able to follow a fluid restriction prescribed by 
their cardiologist leading to excessive water consumption, (Desai & Stevenson, 2012; 
Linhares et al., 2010; Parrinello et al., 2008; Shah, et al., 2013). The best way to follow 
this fluid accumulation is to weigh oneself daily (Linhares et al., 2010; Parrinello et al., 
2008), since there is a direct relationship between amount of fluid consumed in volume 
and the weight of that fluid (Miller and Mullan, 2014). The goal for the patient is to 
maintain their same weight from day to day. 
Adherence to HF regimens is problematic. The average adherence rate to HF 
therapies is reported to be 50% (Bissonette, 2008; Linhares et al., 2010; Perreault, et al., 
2009; Shah, et al., 2013; Wu, Moser, Lennie, & Burkhart, 2008).  One study found that 
28.9% of participants did not adhere to medication regimens due to having HF as a new 
diagnosis, older age, multiple comorbidities and medications, and lack of sleep (Knafl & 
Riegel, 2014). Further, recent evidence demonstrates brain injury in HF patients in the 
areas of the brain responsible for memory, organization, planning, and problem solving 
(Woo, Kumar, Macey, Fonarow, & Harper, 2009). This new evidence may provide a 
possible explanation for some of the adherence issues in HF patients, including failure to 
weigh oneself on a daily basis. If a patient cannot organize the multiple tasks required to 
take care of themselves, if they cannot plan to weigh themselves every morning, if they 
cannot remember that they need to do that or have done that, then it will be difficult for 
patients to weigh themselves on a daily basis, or even figure out what to do with the 
information once they have weighed themselves. For a treatment plan to be successful, 
the patients must have the cognitive skills to comprehend the plan, agree to and be 
involved in the plan of care and rigorously adhere to the plan of care rigorously (Woo et 
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al., 2009). Therefore, the purpose of this study is to examine whether weight changes 
differed based on the presence or absence of cognitive impairment in HF participants 
who were followed in the clinic one to two months after discharge from the hospital after 
an exacerbation of HF.  
Background 
HF greatly impacts the U.S. health care system. Current estimates are that 5.7 
million Americans older than 20 years of age have HF (Mozaffarian, et al., 2015). Each 
year, there are 825,000 new HF cases (Loehr, Rosamond, Chang, Folsom, & Chambless, 
2008) and by 2030 it is estimated that eight million Americans will have HF (Heidenreich 
et al., 2013).  Hospitalization rates for HF are reported at 180 to 190 hospitalizations per 
10,000 people for the years 2007 to 2010 (National Heart Lung & Blood Institute 
[NHLBI], 2012).  Recent estimates place the direct and indirect cost of HF in the US to 
range from $29 billion (de Lissovoy et al., 2010; Gheorghiade, Vaduganathan, et al., 
2013) to $33.7 billion dollars annually (Reed et al., 2010) with an average cost of 
$19,021 for each HF hospitalization (de Lissovoy et al., 2010). The increase in numbers 
of people with HF by 2030 will result in an increase in direct and indirect costs in the 
U.S. of $53 billion (Heidenreich et al., 2013).  Current data reported by Vidic, Chibnall, 
and Hauptman (2015) states that rehospitalization penalties correlated with excess 
readmission rates (ERR) of HF patients  more than any other diagnosis code (0.30; p< 
.001) and that in a regression analysis, the HF ERR explained the most variance in the 
penalty (R2 range 0.21 – 0.44). 
Additional costs for HF management occur when HF patients are readmitted to 
the hospital within < 30 days with the same diagnosis of acute exacerbated HF.  
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According to Jenks, Williams, and Coleman (2009), 26.9% of 30-day re-hospitalizations 
from 2003-2004 were due to HF with HF being the leading cause of all re-
hospitalizations. The Centers for Medicare and Medicaid (Suter et al., 2014) reported that 
in 2012, 22% of HF patients were readmitted nationwide within less than 30 days with 
acute exacerbation of HF, down from 23.5% in 2010. Jencks, Williams, & Coleman,  
(2009) estimated the cost of all re-hospitalizations to be $17.8 billion dollars. As HF is 
the most expensive DRG (Fida & Pina, 2012), it incurs $15 billion in costs annually, just 
in hospital readmissions. In order to reduce HF re-hospitalizations, there needs to be a 
global consensus on the management of HF. 
Guidelines for the management of HF have been developed that advocate 
therapies proven to reduce morbidity and mortality (Jessup et al., 2009; Yancy et al., 
2013). Adherence to these HF therapies such as medication, diet, exercise, and weight 
management is vital to a patient’s ability to manage their HF (Jessup et al., 2009; Yancy 
et al., 2013). Failure to adhere to medication, diet, and therapy regimens results in poor 
blood pressure control, worsening function of the heart muscle, shortness of breath, and 
edema resulting in an increase in hospital re-admissions and mortality (Albert, 2008; 
Mockler, et al., 2009; Wu, Moser, Lennie, & Burkhart, 2008; Yancy et al., 2013). A 
review of the literature reveals that these adherence rates are low. 
Measurements of adherence to HF therapies place the behavior at anywhere from 
15-100%, with an average adherence rate of 50%, depending on the method of 
measurement (Bissonette, 2008; Knafl & Riegel, 2014; Perreault et al., 2009; Wu, Moser, 
Lennie, & Burkhart, 2008). Factors found to influence medication adherence include 
living with someone or being married, having social support, and having more education 
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(Wu, Moser, Lennie, Peden, et al., 2008). Knafl & Riegel (2014) found that having a new 
diagnosis of HF, being of older age, having multiple comorbidities and medications, and 
lack of sleep were important reasons for non-adherence.  Osterberg & Blaschke (2005) 
reported that in the United States, 33%-69% of medication-related hospital admissions 
were due to poor medication adherence (across all illness groups) with a resultant cost of 
approximately $100 billion per year.  For example, controlling hypertension rigorously 
could prevent most occurrences of HF (Perreault, et al., 2009; Yancy et al., 2013). Being 
able to control hypertension requires the ability of the patient with hypertension to take 
their medications exactly as prescribed every day. Commitment to and involvement in the 
plan of care by patients is vital to prevent or manage HF and thus prevent hospital 
readmissions for HF exacerbation.  
One of the most important predictors of adherence is having the cognitive 
function to learn about the medical therapies, to understand them, and to implement them 
(Woo et al., 2009; Wu, Moser, Lennie, & Burkhart, 2008). Several research teams have 
found evidence of cognitive deficits in HF patients, which may contribute to lack of 
adherence to medical therapies and subsequent re-hospitalization (Gallagher et al., 2013; 
Hajduk et al., 2013; Pressler, 2008). Pressler (2008) examined research studies between 
2002-2007 and found that 25% – 50% of HF patients had cognitive impairments.  Hajduk 
et al. (2013) found that 79% of 577 participants (M = 71 years, 44% female) were 
impaired in at least one cognitive domain and impaired memory was associated with 
lower self-care scores (p = .006) in multivariate models.   
Cognitive function is considered to be the sum of multiple abilities and is comprised of 
receptive functions, memory and learning functions, and thinking functions which 
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include organizing information, and expression (Lezak, Howieson, & Loring, 2004; 
Vogels, Oosterman, Van Harten, Gouw, et al., 2007). Cognitive impairment is 
characterized by altered speed of information processing, working memory capacity, and 
reduced long term memory (Athilingam, 2008; Athilingam, King, Burgin, Ackerman, 
Cushman, & Chen, 2011; Cameron, et al., 2009; Harkness, Demers, Heckman, & 
McKelvie, 2011). Woo et al. (2009) have documented areas of brain injury associated 
with executive function in HF patients that cannot be explained by diseases of aging, 
such as cerebrovascular disease, strokes, carotid plaques, or microvascular disease.  
Patients’ abilities to adhere to HF therapies require relatively unimpaired 
cognitive functioning (Woo et al., 2009). Woo et al. (2009), in a study of patients with 
HF, found that brain injury correlated with impaired cognitive function. “Forgetting” was 
the common reason that HF patients gave for not adhering to medications (Conn, Taylor, 
& Miller, 1994; Kairuz, et al., 2008). Many hospitalizations for HF could be prevented by 
improvements in adherence to medical therapies for HF and in lifestyle modifications by 
patients (Moser & Riegel, 2004). 
HF is characterized by fluid congestion that accumulates in the lungs as well as in 
the extremities and abdomen (Desai & Stevenson, 2012; Gruszczynski, Schuster, Regier, 
& Jensen, 2010; Guglin, 2011; Kemp & Conte, 2012; Parrinello et al., 2008).  The 
congestion is associated with shortness of breath (dyspnea) and edema of the extremities 
(Francis & Tang, 2004; Konishi et al., 2009). Measuring the amount of fluid is difficult 
and is accomplished through measuring daily weights and urine output (Lee, et al., 2013; 
Miller & Mullan, 2014; Moser& Riegel, 2004).  Physical examination revealing dyspnea, 
edema, neck vein distention, and increase in body weight are used as clinical surrogates 
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for estimating presence of excess body fluid (Francis & Tang, 2004; Lindenfeld et al., 
2010; Miller & Mullan, 2014). Excess body fluid is also estimated by the use of a right 
heart catheter which may demonstrate elevated filling pressures (Lindenfeld et al., 2010; 
Zile et al., 2011). Since fluid weighs 2.2 lbs per liter (Engineering Tool Box, 2011;Miller 
& Mullan, 2014), then weighing the patient with a common bathroom scale would be an 
readily accessible means of estimating changes in fluid volume (Gruszczynski et al., 
2010; Miller & Mullan, 2014). Treatment focuses on fluid restriction of 1.5 to 2 liters per 
day and the use of diuretics such as furosemide and zaroxolyn to remove excess body 
fluid (Gruszczynski et al., 2010; Guglin, 2011; Lindenfeld et al., 2010; Miller & Mullan, 
2014). This treatment regimen is now being challenged (Aliti et al., 2013; Travers et al., 
2007) and will be discussed in Chapter 2. 
Some research has been done to examine HF patient adherence to medical 
therapies (Albert, 2008; Holst, Willenheimer, Martensson, Lindholm, & Stromberg, 
2007; Lee et al., 2013). Generally, adherence to medical therapies such as diet, 
medications, and low salt diet was about 50-60% (Wu, Moser, Lennie, and Burkhart, 
2008). In a recent study, Knafl and Riegel (2014) found that 28.9% of their 63 adult 
patients with HFrEF (M 62.8 ± 11.6 years) had poor adherence. Very few studies 
examined whether patients weighed themselves or followed a fluid restriction and those 
that did reported a range of only 29%- 50% of patients weighing themselves (Gonzalez et 
al., 2004; Holst et al., 2007; Ni et al., 1999). Ni et al. (1999) reported that thirty-eight 
percent of their sample believed they should drink a lot of fluids, which is exactly the 
opposite of what patients with HF should do.  Even though this study by Ni et al. (1999) 
is old, few other studies on the topic of fluid management were found at this writing 
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(Jessup et al., 2009; McMurray et al., 2012). In another study by Michalsen, Konig, & 
Thimme (1998), 34% of the participants consumed more than 2.5 liters of fluid per day. 
In that study, only 26.3% of patients were aware of the need for fluid restriction or paid 
attention to their daily fluid intake. Only 38.2% of patients weighed themselves regularly, 
even though 86.6% of patients had scales at home.  
Cognitive function was not evaluated in these studies, therefore, it would be 
useful to know if HF patients’ cognitive function were measurably within a normal range 
using standard psychometric tools and if they were able to minimize changes in weight 
by following a treatment plan that included recommended standard therapies such as a 
low sodium diet, fluid restriction, maintenance of their discharge weight, and medication 
appropriate for management of HF (Hunt et al., 2009). There are a limited number of 
studies that link cognitive function and changes in weight and none that focus primarily 
on the relationship of cognitive function to changes in weight (Conn et al., 1994; Kairuz 
et al., 2008; Pressler, 2008). This study will examine whether weight changes differed 
based on the presence or absence of cognitive impairment in HF participants who were 
followed in the clinic one to two months after discharge from the hospital after an 
exacerbation of HF. 
Theoretical Framework 
 The framework for this study is based on Riegel’s Situation-Specific Theory of 
Heart Failure Self-care (Riegel & Dickson, 2008). Influenced by Dorothy Orem’s self-
care theory (1985), Riegel developed a situation specific theory to describe self-care in 
the HF population that involves monitoring oneself for symptoms, recognizing the 
symptoms, evaluating whether the symptoms are related to their HF and determining the 
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degree of severity of the symptoms, treating the symptom according to what they have 
learned from their healthcare providers, and evaluating the effectiveness of the treatment 
(Riegel & Dickson, 2008). According to this theory, self-care in the HF population has 
three components: Self-care Maintenance, Self-care Management, and Self-care 
Confidence (Riegel & Dickson, 2008). Self-care maintenance is the day-to-day business 
of managing one’s diet, weights, medications, and exercise program. Self-care 
management involves picking up on subtle changes in one’s sense of what constitutes 
normal for oneself, analyzing those changes for significance, choosing a treatment from 
among those prescribed for their care, and evaluating whether that treatment was 
effective. To manage their chronic HF condition, patients must have confidence in their 
ability to remember, understand and implement the therapies in their daily life (Riegel & 
Dickson, 2008). Riegel’s Model (2008) is illustrated by the following figure. 
Figure 1: Copyright © Self-Care of Heart Failure Index (Riegel, 2009) 
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 In this model, self-care attributes in HF are defined as weighing oneself daily, 
eating a low sodium diet, taking medications as prescribed, participating in regular 
exercise such as walking, and recognizing HF symptoms such as shortness of breath, 
ankle swelling, and fatigue (Cameron et al., 2009; Gruszczynski et al., 2010). Following 
the model, the patient would be engaged in self-care maintenance by weighing 
themselves every day, eating a low sodium diet, taking medications as prescribed, etc. 
Monitoring oneself for a change in symptoms would also be considered self-care 
maintenance. Should the patient become aware that they experience shortness of breath 
or their weight has gone up by 1-2 pounds over night, then evaluation of those symptoms 
moves them into the Management phase of the model. The patient should be able to 
evaluate that the symptoms are related to their HF in order to implement a treatment plan. 
The treatment plan may be to call their HF nurse or to take a prn diuretic. Afterward, they 
should be able to evaluate that they feel less short of breath or their weight has gone back 
down. Having the ability to evaluate their symptoms and respond appropriately requires 
intact cognitive function. 
 Applying the model to managing weight and preventing weight changes greater 
than 2.0 pounds per day would look like Figure 2. 
Figure 2: Self-care Model examining change in weight 
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It is within this framework that the significance of this study lies. A person’s 
ability to engage in self-care requires the physical and cognitive ability to perform those 
acts (Trupp & Corwin, 2008; Woo et al., 2009). HF patients must have intact cognitive 
function of organizing, planning, sequencing, and calculating in order to maintain their 
level of wellness appropriate for their degree of chronic HF. Applying Riegel’s theory to 
this phase of chronicity is consistent with Self-care Maintenance (Lee et al., 2013; Riegel 
& Dickson, 2008). Additionally, they must have the cognitive skills of analyzing, critical 
thinking, problem-solving, and abstract thinking in order to manage variations in their 
day-to-day physical status. Self-care Management applies to this phase of the HF 
patient’s experience. These cognitive skills are vital to the HF patient’s ability to care for 
themselves and without these skills their HF status deteriorates (Jessup et al., 2009; 
Trupp & Corwin, 2008). This study does not examine day-to-day weight maintenance, 
but instead  sought to describe whether there was a difference in weight magnitude and 
direction from T1 at enrollment to T2, four to eight weeks later in the clinic. 
Research Aims  
Primary Aim: The primary aim of this study was to explore whether weight 
changes differed based on the presence or absence of baseline cognitive impairment in 
HF participants who were followed in the clinic one to two months after discharge from 
the hospital for an acute exacerbation of HF admission. 
Primary Research Question:  Is there a difference in weight change over time in 
HF patients with and without baseline cognitive impairment? 
Secondary Aim: A secondary aim was to explore whether functional status, 
depression, or NYHA Class in HF patients followed in the clinic one to two month after 
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discharge from the hospital for an acute exacerbated HF admission differed according to 
baseline cognitive impairment. 
Secondary Research Question: Is there a difference in functional status, 
depression or NYHA Class at follow-up in those HF patients with and without baseline 
cognitive impairment? 
Third Aim: The third aim of this study was to explore whether there was a 
difference in weight or baseline cognitive function in HF participants who received a 
high number or low number of diuretic dose adjustments one to two months after 
discharge from the hospital for an acute exacerbated HF admission. 
Research Question: Is there a difference in weight change over time in those HF 
patients who had a low number of diuretic dose adjustments versus a high number of 
diuretic dose adjustments when followed in the clinic one to two months after discharge 
from the hospital for an acute exacerbated heart failure admission? 
Research Question: Is there a difference in baseline cognitive status in those HF 
patients who had a low number of diuretic dose adjustments versus a high number of 
diuretic dose adjustments when followed in clinic one to two months after discharge? 
Significance 
This study is significant to nursing education, practice and research because 
patients’ abilities to minimize their weight changes depend on having the cognitive skills 
to take their medications as prescribed, to follow a fluid restriction and low sodium diet, 
and to weigh themselves daily. Patients must be able to analyze the significance of 
variations in their weight and engage in a problem solving process to determine the 
appropriate action to take when they determine that the weight variation is indicative of 
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fluid overload. Because HF is such a serious illness with a multi-pronged approach to 
management, patients must be fully engaged and cognitively competent partners in their 
care.  
There is little research exploring the impact of cognitive function on change in 
weight in HF patients. Yet a patient’s ability to manage their weight is directly linked 
with maintaining euvolemia and maximal cardiac output. Failure to follow a prescribed 
fluid management program and performance of daily weights can destabilize a patient 
clinically, leading to fluid accumulation in the pulmonary, venous, and lymphatic systems 
resulting in exacerbation of HF symptoms and hospital readmissions (Howlett, 2011; 
Hunt et al., 2009; Parrinello et al., 2008).  
These multiple hospitalizations result in setbacks for the patients physiologically, 
as it has been demonstrated that patients have not returned to physiologic baseline at time 
of discharge, showing persistent HF symptoms at discharge (Paul and Hice, 2014 ). 
Additionally, re-hospitalizations for HF are costly for the patients and insurers and are no 
longer being covered by Medicare if they occur within 30 days after discharge from a 
hospital for the same diagnoses (Maliakkal & Sun, 2014). 
Recovery at home can be lengthy with re-hospitalization sometimes occurring 
before the patient’s health status has returned to baseline (Kannel & Ramachandran, 
2004). Early detection of cognitive deficits may facilitate the healthcare providers’ 
abilities to develop interventions for the patient and family to prevent re-accumulation of 
excess fluid in the lungs, thus preventing early and expensive re-hospitalizations 
(Maliakkal & Sun, 2014). Therefore the purpose of this study was to assess whether 
weight changes differed based on the presence or absence of baseline cognitive 
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impairment in HF participants who were followed in the clinic one to two months after 
discharge from the hospital for an acute exacerbation of HF admission.as a part of a 
comprehensive treatment plan for HF. 
Implications for Nursing Practice  
Nurses play a critical role in teaching patients about their diseases, medications, 
and all their medical regimens, such as weighing themselves, during hospitalization and 
at discharge (Paul & Hice, 2014). HF patients need to have the cognitive skills to learn 
and retain the information and then to translate that into their home environment in order 
to manage their weight and maximize the benefit of their medical therapies to prevent 
hospital re-admissions due to exacerbation of HF (Lee, et al., 2013). It would be 
beneficial for nurses to include the assessment of cognitive function as part of discharge 
planning.  
HF experts recommend systematic assessment of cognitive function in HF 
patients (Cameron et al., 2009; Lee et al., 2013; Pressler et al., 2010; Riegel & Dickson, 
2008). Additionally, while the U. S. Preventive Services Task Force found inconsistent 
and insufficient evidence to recommend routine screening for cognitive function among 
all older adults to identify early cognitive changes, their Guideline report also stated:  
Early recognition of cognitive impairment,…, allows clinicians to anticipate 
problems the patient may have in understanding and adhering to recommended 
therapy. This information may also be useful to the patient’s care-givers and 
family member in helping to anticipate and plan for future problems…. (Boustani, 
Peterson, Hanson, Harris, & Lohr, 2003, p. 925).  
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The 2014 update (Moyer, 2014) is essentially unchanged, stating that the evidence 
for screening for cognitive impairment is lacking and the ability to assess the harms of 
screening versus the benefits is indeterminable. Of importance is Moyer’s (2014) 
statement that it was not possible to find any published literature that demonstrated any 
effect, positive or negative on the effect of cognitive screening on decision making or 
planning by either the patients, their healthcare providers, or their caregivers. Lack of 
such evidence mandates further research on the impact of cognitive function screening on 
discharge planning in HF patients. 
Nurses can take the lead to incorporate an assessment of cognitive function in HF 
patients as part of discharge planning. Further research on the impact of cognitive status 
on patients’ readmission rates and weight changes in HF patients is vital due to the dearth 
of research documenting this impact. Because of the need to for patients to organize and 
plan for their daily weights and fluid consumption, to be able to calculate the number of 
liters to drink, and to problem-solve discrepancies in their fluid and weight 
documentation, patients need to have full cognitive function in order to complete these 
tasks. If patients have deficits in the Executive Function areas of their brain, due to HF or 
other reasons, they will not be able to perform these tasks. Therefore, screening for mild 
cognitive impairment should be incorporated into discharge planning for HF patients. 
This study provides a better understanding of the impact of cognitive function on change 
in weight after discharge from the hospital. 
Definition of Terms 
Heart Failure: HF is a syndrome of progressive deterioration of right and/or left 
ventricular function (Eichhorn & Bristow, 2004) and is the reduction in the ability of the 
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myocardium to pump enough blood to the tissue to meet the cellular needs for 
oxygenation (Hoyle & Kahl, 2006; Parrinello., et al., 2008). This reduction in pump 
function results in neurohormonal shifts, fluid retention, myocardial hypertrophy 
followed by dilation and subsequent contractile failure due to over-stretched myocardial 
fibers (Eichhorn & Bristow, 2004; Izumo & Pu, 2004; Katz, A.M., 2004). In this study, 
HF was defined as being documented in the medical record as having an 
echocardiographic ejection fraction of ≤ 40% in the last 12 months, coupled with 
documented clinical signs and symptoms of dyspnea, edema, abdominal distention, 
and/or neck vein distention. 
 Cognitive Function: Cognitive function, which comprises many capabilities, is 
measured by observing behavior in multiple domains, such as memory and learning 
functions; thinking functions, which include organizing information, and expressive 
functions (Lee, et al., 2013; Lezak et al., 2004; Vogels, Oosterman, Van Harten, Gouw, et 
al., 2007; Woo, Kumar, Macey, Fonarow, & Harper, 2009). In this study, these domains 
were assessed using the Montreal Cognitive Assessment Tool (Lee et al., 2013; 
Nasreddine et al., 2005). 
 Change in Weight: Body weight is the total weight of the patient measured in 
pounds.  In a hemodynamically stable patient, the body weight will remain basically 
stable from day to day (± 2.0 lbs.) (Moser & Riegel, 2004). In this study, the change in 
weight of the participant was the difference in weight from enrollment (T1) to follow-up 
in the clinic (T2) using dedicated research scales.  
 Diuretic Dose Adjustments: It is the standard of practice with the HF cardiology 
specialists at Penn Presbyterian Medical Center to have a HF nurse contact HF patients 
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within 72 hours after discharge from the hospital following an acute exacerbation of HF. 
One of the purposes of this contact is to adjust the dose of the diuretic or add a prn 
diuretic as appropriate, based on patient reports of symptoms or daily weights. The nurse 
records any diuretic dose adjustments in the patient’s medical record. In this study, the 
number of diuretic dose adjustments (including addition of a prn diuretic) was tracked 
between discharge and the clinic visit at 4-8 weeks after discharge. 
Summary 
 HF is a syndrome resulting from a variety of cardiac conditions such as 
myocardial infarction, valve abnormalities, under treated hypertension, etc. As the 
population of the United States (US) continues to age, the incidence of HF will continue 
to increase. More people are surviving cardiac conditions which previously were lethal, 
which further increases the number of people living with HF (Heidenreich et al., 2013). 
As a result, there will be an increased burden on the healthcare system to keep these 
patients out of the hospital and successfully treat HF patients in the home.  
There are multiple, complex therapies to manage HF in the community 
environment, requiring the HF patient to be an engaged, conscientious partner in their 
own care. However, the association between HF and changes in cognitive function which 
impairs the HF patient to manage their therapies has been demonstrated in several 
studies. Changes in cognitive function can be very subtle. A patient’s apparent 
appropriate behavior, such as knowing who he is and where he is, could lead the average 
observer to conclude that the individual is fully competent to care for himself. Brain 
injury in HF patients in the areas of the brain responsible for attention deficits, short term 
memory, complex reasoning, abstract thinking, organization, sequencing, and patterning 
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can render a person unable to organize complex tasks, remember to weigh themselves, or 
to make the connection between a two pound weight gain and the pathophysiology of 
their HF. There is a paucity of research on the association between cognitive function in 
HF patients and their ability to minimize weight changes after a hospitalization for acute 
exacerbation of HF. It is therefore necessary to examine this relationship in order to 
document whether it is necessary for healthcare providers to perform sensitive cognitive 
screenings in order to ensure that patients are capable of managing their weight in the 
home environment to keep changes in weight to a minimum.   
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Chapter 2: Review of the Literature 
Introduction 
Heart failure is a progressively deteriorating condition of heart function that has a 
very large impact on healthcare services utilization nationally (Lindenfeld et al., 2010; 
Shah, et al., 2013). The poor pumping action of the heart results in accumulation of fluid 
in the lungs and extremities, which causes the patients to experience dyspnea with 
exertion which interferes with their activities of daily living and even their ability to be 
gainfully employed (Aliti et al., 2013); Desai & Stevenson, 2012; Jessup et al., 2009; 
Lindenfeld, et al., 2010; Linhares et al., 2010;). Patients with HF (HF) are expected to 
adhere to many therapies in the management of their chronic illness, including, but not 
limited to medications, low sodium diet, fluid restriction, daily weights, and an exercise 
program (Heidenreich et al., 2013; Knafl & Riegel, 2014; Riegel & Dickson, 2008; 
Salyer, Schubert, & Chiaranai, 2012; Yancy et al., 2013). The complex nature of the 
therapies for this condition are so challenging, even for those patients with intact 
cognitive function, that non-adherence to prescribed medical therapies is very high 
resulting in frequent hospitalizations, even re-hospitalizations within less than 30 days, 
resulting in a strain on health care economics, poor quality of life, and high mortality 
(Jencks et al., 2009; Knafl & Riegel, 2014; Lee, Moser, Lennie, & Riegel, 2011; Thomas, 
2007).  
Little research has been done to measure the impact of cognitive function on 
change in weight in patients. This literature review examines the evidence surrounding 
the care of HF patients, and the pathophysiology of HF and its therapies. The components 
of cognitive function and weight maintenance will also be examined along with 
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depression, which is associated with cognitive function. Functional activities, which have 
been shown to correlate strongly with cognitive function, are also reviewed. These 
constructs are viewed from the perspective of self-care using the Situation –Specific 
Theory of Heart Failure Self-care by Dr. Barbara Riegel (Riegel & Dickson, 2008). 
Heart Failure 
 An important cause of HF exacerbations is failure by the patient to adhere to 
medication, diet, daily weights, and therapy regimens, which results in poor blood 
pressure control, worsening function of the heart muscle, shortness of breath, and edema 
(Cotter, Felker, Adams, Milo-Cotter, & O'Conner, 2008; Parrinello, 2008; Shah, et al., 
2013). These symptoms result in an increase in hospital re-admissions and mortality 
(Parrinello, 2008; Shah, et al., 2013; Wu, Moser, Lennie, & Burkhart, 2008).  
Normal heart function is associated with a state of euvolemia, where the amount 
of fluid consumed is balanced with the amount of fluid excreted through the kidneys or 
transpired through the lungs, skin, and GI tract (Parrinello, 2008). With normal heart 
function, fluid does not accumulate in the lungs or extremities causing a limitation to 
one’s ability to engage in activities. Once the heart begins to fail, then the balance 
between fluid consumed or excreted shifts, resulting in an increase in total body water. 
The body then develops many mechanisms to restore itself to a compensated state (Cotter 
et al., 2008; Parrinello, 2008; Zile et al., 2011; Zuccalà et al., 2005). 
HF patients in distress usually present with shortness of breath (SOB) or dyspnea, 
especially on exertion (DOE) and easy fatigability. Clinical signs of HF include crackles 
in the posterior lung fields, swelling in dependent areas of the body, usually 
legs/ankles/feet, abdominal enlargement, distended neck veins, and a gallop sound heard 
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during cardiac auscultation (Desai & Stevenson, 2012; Francis & Tang, 2004; Parrinello, 
2008; Yancy et al., 2013). Diagnostic tests that aid in the diagnosis of HF include chest 
X-rays that show increased radiopacities in the bilateral lung fields and enlargement of 
the heart silhouette. The echocardiogram may reveal an ejection fraction of ≤ 40% in the 
setting of systolic dysfunction, but is of no help in a HF diagnosis in the setting of 
preserved left ventricular function where the ejection fraction appears to be within normal 
limits (40% - 75%) (Francis & Tang, 2004; Lindenfeld et al., 2010; Parrinello, et al., 
2008; Yancy et al., 2013). If a right heart catheter is inserted to assist with diagnosis and 
management of the HF patient, then the pulmonary and left ventricular end-diastolic 
measurements will be elevated and the cardiac index will be reduced, usually < 2.0 
(Francis & Tang, 2004; Zile et al., 2011). 
 Management of HF is very complex. Non-pharmacological therapies have 
historically included a fluid restriction of 1.5 to 2 Liters of fluid per day, low sodium diet 
of 1.5 to 2 Gm per day, and exercise (Gruszczynski et al., 2010; Moser & Riegel, 2004; 
Yancy et al., 2013). The patient is instructed to weigh themselves every day and to call 
the cardiologist’s office for an overnight weight gain of 2 pounds or more or for a 5 
pound weight gain in a week (Lindenfeld et al., 2010; Yancy et al., 2013).  
Fluid and sodium restriction. 
However, there is currently a developing controversy against that practice of 
restricting fluid and sodium based on some research done by Travers et al. (2007) and 
Aliti et al. (2013). In a single-blinded, randomized study of two groups, one fluid 
restricted (n = 34) and the other not (n = 33), it was found that there was no significant 
difference in clinical stability of serum urea, creatinine, and sodium between the groups 
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(p = .17) nor in time to discontinuation of intravenous diuretic therapy (p = .70) (Travers 
et al., 2007). Since the N was small, a larger randomized trial was recommended.  
Aliti et al. (2013) argued that this practice had never really been studied in a 
randomized clinical trial. Seventy-five patients with HF (ef M = 26%) were divided into 
two groups, one with an 800 mL/d fluid restriction and 800 mg/d sodium restriction while 
the other received a standard hospital diet with liberal fluid and sodium intake for up to 
seven days while hospitalized with acute decompensated HF. There was no significant 
difference in weight loss between the two groups (0.25 kg [95% CI, -1.95 to 2.45]; p = 
.82). Thirst was worse in the Intervention group (p = .01). There was no significant 
between-group difference in the readmission rate at 30 days (p = .41). Their conclusion 
was that restricting fluid and sodium had no effect on weight loss or clinical stability 
(Aliti et al., 2013).  
The Aliti et al. study (2013) elicited significant controversy in the journals 
(Cheitlin, 2013; Rami, 2013). Cheitlin (2013) took issue with the population of HF 
patients who enrolled in the study, stating that of the potential pool of patients admitted 
during that time frame to their hospital, only 9% were actually enrolled, suggesting that 
the population was a small, biased, convenience sample. Another point made by Cheitlin 
(2013) was that the patients had already received up to 36 hours of diuretic therapy 
before being enrolled in the study, and that there was no way to monitor for patients 
sneaking extra fluid or food high in sodium. Cheitlin (2013) pointed out that management 
of patient hospitalized for acute decompensated HF is different from management of 
stable outpatients with HF.  
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A different review noted the same flaws to the Aliti et al. study as Cheitlin above, 
but took a middle of the road conclusion (Rami, 2013). Rami (2013) stated that the 
aggressive salt and fluid restriction implemented in Aliti’s et al. (2013) protocol would 
activate harmful neurohormonal pathways, but that liberalization of fluids and salts on all 
HF patients admitted with decompensation would be just as harmful, recommending the 
ACCF/AHA guidelines of a more reasonable approach appropriate for individual 
patients. The 2013 ACCF/AHA guidelines state that fluid restriction is reasonable in 
stage D patients, especially in the setting of hyponatremia (Yancy et al., 2013). In citing 
the study by Travers et al. (2007), it is felt by the ACCF/AHA that fluid restriction in less 
advanced stages of HF are not helpful (Yancy et al., 2013).  
Pharmacologic therapies include diuretics to remove fluid (Guglin, 2011; 
Parrinello, 2008; Rami, 2013), antihypertensives from the Angiotensin-Converting 
Enzyme Inhibitor or Angiotensin Receptor Blocker families to reduce preload and 
afterload and occasionally digoxin to improve contractility (Albert, 2008; Lindenfeld et 
al., 2010; Yancy et al., 2013). Many patients have an average of 10 medications which 
they must take on a daily basis making adherence a significant problem due to many 
factors including expense, but also due to confusion (Albert, 2008; Knafl & Riegel, 
2014). For this reason it is vital that patients have fully intact cognitive function in order 
to take their medications as prescribed, as well as set up their medication administration 
box, with the pills organized and sequenced as to right medications, right times, and right 
doses.  
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Self-care in heart failure. 
Dr. Riegel pioneered research studies designed to describe self-care abilities in 
HF patients (Carlson, Riegel, & Moser, 2001; Riegel, Carlson, & Glaser, 2000; Riegel & 
Dickson, 2008). Self-management refers to a patient’s ability to identifying signs and 
symptoms in themselves and responding appropriately according to information provided 
by their healthcare provider to control their HF symptoms (Riegel & Dickson, 2008). In 
this model, the role of cognitive function is described thoroughly as a main underpinning 
of the HF patient’s ability to engage in self-care (Riegel et al., 2000). In an early study, 
209 elderly (M 73 years), Class III HF patients responded to the Self-care of HF 
Instrument (Rockwell & Riegel, 2001). It was found that patients with higher education 
and those who were symptomatic were more likely to engage in self-care than those who 
were poorly educated or asymptomatic.      
In one of the initial studies, 139 participants (age 69.27 +/- 13.88 years; 74% 
male; 39% Class III HF) (Carlson, et al., 2001) were recruited to document self-care 
abilities. Participants completed an investigator-developed survey mailed to their home 
after discharge from the hospital. About 72% of participants reported some degree of 
functional impairment, half of whom reported marked limitations in ordinary activity. 
Visual and hearing impairments further contributed to self-care difficulties. Most patients 
(88%) claimed to follow a low-sodium diet, although 12% admitted to not restricting 
their sodium intake. Sudden weight gain was not recognized by 60% of responders as 
being a symptom of HF(93.8% of newly diagnosed HF patients vs 33.3% of patients 
experiences with HF, p = .0001). In the domain of self-care management behaviors, 32% 
reported increasing their diuretic dose. For sudden weight gain, 63.3% reported 
26 
Cognitive function and weight in HF patients 
decreasing the sodium intake, increasing their diuretic dose (46.9%), and decreasing their 
fluid intake (44%). Less than half the group (45.7%) felt very or highly confident in their 
ability to take action to relieve symptoms.  
A follow-up study (Riegel & Carlson, 2002), was designed to discover what HF 
patients perceive to be the facilitators and barriers to managing their own self-care. 
Qualitative data were obtained from 26 HF patients (mean age 74.4 +/- 10 years; length 
of time with HF 3.4 +/- 3.86 years, 65.4% male). Common challenges elicited from these 
patients included, among several challenges, coping with the treatment regimen and not 
feeling as if they had enough knowledge to manage their own care. Additional 
information came out of the focus groups that included having difficulties recognizing 
symptoms as being related to HF and following the treatment regimen. Many patients 
reported trying to improve their knowledge and coping skills by buying books to read 
more about HF and their medications. These results demonstrated that many HF patients 
had poor self-care abilities, from following a standard HF therapy program of 
medications, diet, and daily weights, to recognizing their symptoms, to understanding 
that the symptoms were related to HF, and then responding appropriately.  
Lee et al., (2011) found in a study of 195 older adults with HF, that patients who 
engaged in self-care management had as low a risk of an event (all-cause mortality, 
hospitalization or emergency room admission) during follow-up as those who were 
symptom-free (p < .05). This finding speaks to the importance of HF patients being able 
to manage their own symptoms. In a study examining cognitive impairment and self-care 
in HF, the MoCA and the 9-item European Heart Failure Self-care Behaviour Scale were 
used to measure cognitive function and self-care respectively in a sample of 577 patients 
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(M 71 years, 44% female) hospitalized for HF at five medical centers in the U.S. and 
Canada (Hajduk et al., 2013). They found that 79% of their sample (n = 453 patients) 
were impaired in at least one cognitive domain and that impaired memory was associated 
with lower self-care scores (p = .006). These studies demonstrate the link between HF 
patients’ abilities to manage their own care and the impact of cognitive function on that 
ability. 
As can be seen from the above discussion, HF is a very complex and debilitating 
condition requiring significant personal and social resources. The economic impact on 
society is profound and will increase over the next forty years as the Baby-boomer 
generation continues to age and therapies for preventing deaths from myocardial 
infarctions and cardiomyopathies improve. The HF patients must be fully engaged in 
their own care and they must have intact cognition in order to follow a complex regimen 
of pharmacologic and non-pharmacologic therapies, all aimed at keeping the cardiac 
function optimal and at keeping the patient out of the hospital with acute exacerbations of 
HF. 
Variables 
Cognitive Function. 
Intact cognitive function is critical to a patient’s ability to adhere to complex 
medical therapies for the treatment of HF. Defining what is meant by cognitive function 
is important to being able to measure it. Cognitive function is considered to be the sum of 
multiple abilities that are measured by observing behavior in multiple domains (Lezak et 
al., 2004; Vogels, Oosterman, van Harten, Scheltens, et al., 2007) and is comprised of 
receptive functions, memory and learning functions, thinking functions which include 
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organizing information, and expressive functions (Lezak et al., 2004; Ogren, Fonarow, & 
Woo, 2014). Within these functional domains are the attributes of executive and 
visuospatial capabilities along with mental speed and attention (Levin et al., 2014; Ogren 
et al., 2014; Pressler, et al., 2010; Vogels, Oosterman, van Harten, Scheltens, et al., 
2007). In this study, these attributes were organized into the domains of Memory, 
Executive Function, Visuospatial abilities, Language, Mental Speed and Attention.  Some 
of the factors that influence cognitive function, assuming the absence of delirium, drugs, 
and electrolyte imbalance, are functional abilities (Katz, S., 1983; Meiner, 2011) and 
depression (Butters et al., 2004; Cameron, Worrall-Carter, Riegel, Lo, & Stewart, 2009; 
Clark & McDougall, 2006; Frasure-Smith et al., 2009; Meiner, 2011; Pullicino et al., 
2008). 
A review of the literature revealed a variety of testing tools and neurological 
perspectives on cognition. Three studies were found that examined Memory, Executive 
Function, Visuospatial abilities, Language, Mental Speed and Attention in HF patients 
Cognitive performance was examined in patients with and without HF (Serber, et al., 
2008) using the Mini Mental State Exam (MMSE), Trail Making A & B from the 
National Institute of Health Stroke Scale, and the Watson Clock-Drawing test. These test 
scores were then compared to magnetic resonance T2 relaxometry. All participants scored 
normally on the MMSE, so it was discarded from analysis. Using the other measuring 
tools, up to 20% of the participants had abnormal cognitive scores and significant brain 
injury appeared in the participants who had the abnormal test scores. Clock drawing 
scores related to the greatest extent of injury, so as a result may be the most sensitive for 
evaluating overall structural injury. 
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In a study comparing clinical testing against brain structure and function, MRI 
research, also using T2 relaxometry, was done on younger HF patients to document the 
presence of cerebral atrophy (Woo et al., 2009). Proton-density and T2-weighted images 
were acquired from 13 HF patients (age 54.6 +/- 8.3 years, LV EF .28 +/- 0.07) and 49 
controls, with similar demographics. Higher T2 relaxation values, indicating injured brain 
areas (p < .005), emerged in sites that control autonomic, analgesic, emotional, and 
cognitive functions in the HF patients. The areas involved correlate with inhibition of 
pain and emotional lability, including depression. There was a pattern of injury which is 
related to short-term memory deficits, attention deficits, difficulty with complex 
reasoning, and confusion. No brain areas showed higher T2 values in the control group. A 
limitation of this study was that patients who were enrolled had a mean age of 54.6 years 
and whose HF was mostly nonischemic in origin, which does not reflect the 
demographics of the vast majority of HF patients. The strength of this study was that 
these patients did not have age-related changes in white and gray matter, ischemia caused 
by atherosclerotic cerebral blood vessels, and/or multiple comorbidities. Therefore, the 
changes in the MRI reflected the contribution of HF toward brain injury. 
Finally, Pressler et al. (2010) investigated whether cognitive impairment was a 
predictor of mortality in adults with systolic HF. The study population was 166 stable 
outpatients (M = 65.6 ± 13.8 years) with HFrEF who completed a battery of 
neuropsychological and depressive symptom testing and was followed for a year. The 
cognition battery comprised tests of short-term and delayed memory, visuospatial ability, 
cognitive processing speed, and executive function. Twenty-one of the 145 patients who 
died scored lower on measures of global cognitive function, memory, and executive 
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function, with memory loss being the most predictive cognitive function variable (χ2 = 
17.97, p < .001). This study was the first to report that cognitive impairment, especially 
in the areas of working memory and executive function, were predictors of one year all-
cause mortality.  
These three studies examined cognitive function in HF patients using T2 
Relaxometry (two studies) and a variety of cognition batteries that were comprised of 
various memory testing, visuospatial skills, processing speed, and executive function. All 
three found that memory and executive function were impaired in HF patients. However 
the etiology of the injury to the brain and these specific areas is unclear. Debate centers 
around decreased cardiac output, low blood pressure, low cerebral perfusion pressure and 
the occurrence of emboli in 20-23% of patients, but there is no consistency with the 
presence of emboli and the presence of injury (Ogren, Fonorow, & Woo, 2014). Other 
causes of this brain injury are speculated to be nutritional deficits, specifically thiamine 
deficiency, which affects 33% of HF patients (Ogren et al., 2014). Sleep-disordered 
breathing is also postulated as a cause, since over half of HF patients have obstructive 
sleep apnea (Ogren et al., 2014). 
Cognitive Impairment. 
Cognitive impairment is a term referring to any of several causes of diminished 
cognitive skills, such as delirium and dementia (Meiner, 2011; Muwaswes, 1993). 
Delirium is a rapidly occurring state of reduced ability to maintain attention to external 
stimuli and is characterized by disorganized thinking or rambling speech and is usually 
reversible due to correction of serum imbalances such as low sodium levels or reduction 
of serum levels of offending drugs such as anesthesia (Meiner, 2011; Muwaswes, 1993). 
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Dementia, on the other hand, is a condition that develops over many years and is 
characterized by short and long-term memory problems, impaired abstract thinking skills 
and judgment, difficulty in engaging in self-care activities such as bathing and dressing, 
and is not reversible (Meiner, 2011; Muwaswes, 1993).  
Cognitive impairment occurs on a continuum between normal cognitive function 
and total cognitive disability/dementia and is evidence of diminished cognitive skills 
which may include short term memory disorders, and problems with organizing and 
problem solving ( Lee, et al., 2013; Ogren, Fonarow & Woo, 2014; Pressler, Kim, Riley, 
Ronis and Gradus-Pizlo, 2010). Cognitive impairment can be caused by normal diseases 
of aging such as Alzheimer’s disease, as well as by depression and altered vision, hearing 
and acute medical conditions (Meiner, 2011).  
Cognitive impairment can be documented with any of several measuring tools 
such as the Mini Mental State Exam (MMSE) (Folstein, Folstein, & McHugh, 1975), 
multiple clock drawing tools, the Short Portable Mental Status Questionnaire (Pfeiffer, 
1975) and many others. Declining cognitive functioning is characterized by altered speed 
of information processing, working memory capacity, and long term memory (Lee, et al., 
2013; Ogren, Fonarow, & Woo, 2014; Pressler et al., 2010). 
Increasingly, cognitive impairment is recognized as being associated with HF 
(Dodson, Truong, Towle, Kerins, & Chaudhry, 2013; Lee, et al., 2013; Ogren, Fonaorw, 
& Woo, 2014; Pressler et al., 2010; Pressler, Suubramanina, et al., 2010; Wolfe, Worrall-
Carter, Foister, Keks, & Howe, 2006). Research has shown that the cognitive skills of 
memory and learning, attention deficits, problem-solving, abstract thinking, critical 
thinking skills, and visuospatial skills, as well as skills associated with executive 
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functioning, such as sequencing and organizing, are impacted (Bauer,  et al., 2012; Beer 
et al., 2009; Heckman et al., 2007; Ogren et al., 2014; Wolfe et al., 2006).  
An increasing number of studies examining the prevalence and correlates of 
cognitive impairment in HF are being conducted with the goal of identifying the 
contributors to cognitive impairment so that interventions can be developed to address 
these problems, improve quality of life and reduce re-admissions and expense. According 
to Ogren, et al. (2014), impairments in Executive function are caused by injuries to the 
prefrontal and anterior cingulate cortices, where the anterior cingulate shows a loss of 
gray matter in HF patients. The caudate nucleus is also damaged, which has an important 
role in goal directed actions, such as deciding on which behavior to engage in to achieve 
a desired outcome. An example of dysfunction in the caudate nucleus would be having 
difficulty following HF medical and nursing therapies resulting in deficits in self-care 
skills (Ogren et al., 2014).  
In a study examining the profile of cognitive impairment in chronic HF, 58 
outpatients (mean age 68.7 ± 9.1 years, 26% female, mean LVEF 27% ± 7.2) who did not 
have a previous diagnosis of dementia. The participants completed with an extensive 
battery of neuropsychological tests of cognitive speed, executive function, memory, 
verbal skills, and visuospatial function (Vogels, Oosterman, Van Harten, Gouw, et al., 
2007). The results were that 14 (25%, p = .04) of the 58 HF patients showed more 
problems with executive function, memory, language, mental speed and attention 
compared one (4%) of 26 healthy controls. The factors associated with cognitive 
impairment were smoking (p .01), lower diastolic blood pressure (p .008), and duration of 
heart disease (p =.02). Neuroimaging was used to investigate the relationship between 
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cerebral abnormalities detected by MRI and cognitive performance. Medial temporal lobe 
atrophy (MTA) correlated with memory (r = - 0.353, p < 0.01), with executive functions 
(r = - 0.383, p < 0.01) and the MMSE (r = - 0.343, p < 0.05). The MMSE score ranged 
from 24 to 30 points out of a possible 30 points (MM = 27.6), which would not have 
identified any cognitive impairment. 
A study examining factors contributing to cognitive impairment in HF evaluated 
14,089 participants of the Reasons for Geographic and Racial Differences in Stroke 
cohort (Pullicino et al., 2008). It was revealed that participants with HF were 1.51 times 
more likely to have cognitive impairment than those without HF (95% CI: 1.15-1.96). 
Characteristics associated with cognitive impairment in HF were older age, male gender, 
and black race (p < .0001). Additional characteristics associated with cognitive 
impairment were annual income < $25,000, education ≤ high school, current alcohol and 
tobacco use, and having the comorbidities of diabetes, hypertension, atrial fibrillation, 
heart disease, low hemoglobin (< 13), depression, and prior stroke (all with p < .0001).  
Beer et al (2009) examined contributors to cognitive impairment in HF by having 
31 patients with HF (LVEF < 40%, mean age 54.3, male 83.9%) and 24 controls without 
HF (mean age 56.1, male 83.3%) participate in a battery of cognitive testing (the 
CAMCOG portion of the Cambridge Examination for Mental disorders of the Elderly), a 
depression scale, a 6-minute walk test, and semi-quantitative magnetic resonance imaging 
(MRI). The results showed that the HF patients had a mean CAMCOG score of 93.5 (SD 
6.1) compared to 99.9 (SD 2.4) in the healthy participants (p < .001). Characteristics 
associated with statistical significance were shorter distance on the 6-minute walk (p < 
.001), higher rennin concentration (p < .001), higher aldosterone concentration (p .003), 
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and more prominent right medial temporal lobe atrophy (p .03) which is consistent with 
memory disorders.  
Research has been published in the nursing literature in the last 20 years to 
examine cognitive function in HF patients due to the importance that patients’ abilities to 
adhere to HF therapies and engage in self-care activities require relatively unimpaired 
cognitive functioning.  In a study examining 148 participants (57 ± 12 years) with Class 
III/IV HF, 33.1% of the participants had mild cognitive impairment using 26 as the cutoff 
on the MoCA tool (Lee et al., 2013). When 24 was used as the cutoff, 14.2% had mild 
cognitive impairment, but improved ability to detect blunted self-care skills. Participants 
who scored lower reported 21.5% worse self-care skills than those who scored > 26. 
Bauer, & Pozehl (2010) explored patterns of cognitive impairment to see whether 
there were differences between systolic and diastolic HF etiologies. Forty eight adults (75 
± 9 years) in the systolic dysfunction group were compared to 32 adults (68 ± 15 years) 
in the diastolic dysfunction group on the Repeatable Battery for the Assessment of 
Neuropsychological Status (RBANS), Trail Making Test Part A and B, and Letter 
Fluency. They found that 66% of the participants with systolic dysfunction were impaired 
on memory tests vs. only 21% of those participants with diastolic dysfunction, with 
immediate (p = .027) and delayed memory (p = .001) being more significantly impaired 
in the systolic dysfunction group.   
Another nursing study to assess cognitive function in HF patients (LVEF < 40%) 
examined 38 patients (mean age 64 ± 7.62; 76.3% male) using several 
neuropsychological tests including the Wechsler Abbreviated Scale of Intelligence 
(WASI), the Wisconsin Card Sorting test (WCST), the Schonell Graded Word Reading 
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Test SGWRT), and the Repeatable Battery for Assessment of Neuropsychological Status 
(RBANS) (attention, immediate and delayed memory) (Wolfe et al., 2006).The results of 
the study revealed impaired memory and impaired executive functioning with RBANS 
scores being significantly different from age-expected scores (p < 0.001). The immediate 
memory score was significantly lower than the age-adjusted norms (p = 0.014) and 
likewise the delayed memory score (p < 0.001). The Visuospatial constructional index 
score was also less than age-expected scores (p < 0.001). Similar results were found for 
the WCST tests of executive functioning (p < 0.001).  
A descriptive, correlational design was used to describe cognitive impairment in 
HF patients (Riegel, Bennett, et al., 2002). Four screening measures of cognition were 
tested in 42 patients with HF. Cognitive impairment was detected in 12 (28.6%) of the 
participants. The Draw-a-Clock Test indicated impairment in 50% of the 12 impaired 
patients, while the other tests, including the MMSE, varied in effectiveness. The Draw-a-
Clock test used in this study cannot be used to detect problems with verbal learning or 
delayed recall. The authors recommended using it in conjunction with other tests.  
There has been more research on cognitive function in HF resulting in evidence of 
cognitive impairment due to brain injuries from HF. A study of prevalence and 
documentation of cognitive impairment in older adults with HF showed that cognitive 
impairment was present in 132 of 282 patients (46.8%) (Dodson, et al., 2013). Using the 
Folstein Mini-Mental State Examination, 25.2% scored mild cognitive impairment and 
21.6% scored in the moderate to severe range for cognitive impairment. Hajduk, et al. 
(2013) assessed cognitive impairment in the domains of memory, processing speed, and 
executive function using a standardized neuropsychological battery of tests to find an 
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association between cognitive impairment and adherence to self-care in patients 
hospitalized with HF. They studied 577 patients and found that 79% were impaired in at 
least one cognitive domain and that impaired memory was associated with lower self-care 
scores (p = .006) (Hajduk et al., 2013).  
Another in-hospital study investigated the prevalence of cognitive impairment in 
the cognitive domains of memory, processing speed, and executive function using 
standardized measures (Levin et al., 2014). Levin et al. (2014) studied 744 patients 
hospitalized with acute decompensated HF and found that 593 (80%) were impaired in at 
least one cognitive domain and that 17% were impaired in all three cognitive domains.  
These studies highlight the importance of intact cognitive function on HF 
patients’ abilities to perform daily weights, follow a fluid restriction and take diuretic 
medications as prescribed. The cognitive skills required to perform these tasks include 
organizing, sequencing, planning, problem-solving, and math calculations. The area of 
the brain that performs these tasks is the Executive Function area of the brain and this is 
precisely the area of the brain that has demonstrated damage in MRI’s of the brain 
reported in the literature (Vogels et al., 2007; Woo et al., 2009). Therefore, if HF patients 
have this brain damage, then they will be unable to perform the tasks of organizing their 
medications, calculate the amount of fluid they are allowed to drink, and remember to 
weigh themselves, or even problem-solve the meaning of changes in their weight. 
 Cognitive Assessments. 
 There is very little research done on screening for cognitive function in HF 
patients (Athilingam et al., 2011; Athilingam & King, 2007-2008). A review of the 
literature reveals a paucity of cognitive function screening tools for use by the bedside 
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clinician to quickly and accurately assess patients and to plan for their care in the 
community setting (Athilingam & King, 2007-2008; Pressler, 2008; Riegel, et al., 2002). 
Just in the last decade, a new screening tool has been developed called the Montreal 
Cognitive Assessment (MoCA) tool that may provide the bedside clinician with a rapid, 
accurate assessment of cognitive function that will not be a burden on seriously ill HF 
patients who fatigue easily (Nasreddine et al., 2005). The testing components of the 
MoCA are drawn from multiple testing tools, such as the National Institutes of Health 
Stroke Screening Tool (NIHSS) (NIH, 2009), the Mini-Mental State Exam (Folstein, et 
al., 1975), and the Clock Drawing test (Watson, Arfken, & Birge, 1993). These 
components are designed to screen for abnormalities in the Executive Function areas of 
the brain, including visuospatial capabilities, verbal, and calculation capabilities 
(Nasreddine et al., 2005). 
 The MoCA has been tested on a wide variety of populations such as those with 
Alzheimer’s Disease (Luis, Keegan, & Mullan, 2009), cardiovascular disease 
(McLennan, Mathias, Brennan, Russell, & Stewart, 2010), aging issues (Koski et al., 
2009), Huntingdon’s Disease (Videnovic et al., 2010), Parkinson Disease (Dalrymple-
Alford et al., 2010), Stroke (Godefroy et al., 2011; Pendlebury, Cuthbertson, Welch, 
Mehta, & Rothwell, 2011), Stroke Rehabilitation (Aggarwal & Kean, 2010), and 
substance abuse disorders (Copersino et al., 2009). While most published studies report 
participants from the outpatient setting, the MoCA has also been tested on patients in the 
acute care setting (Godefroy et al., 2011) and an in-patient rehab setting (Aggarwal & 
Kean, 2010). The MoCA has also been tested on HF patients (Athilingam, 2008; 
Athilingam et al., 2011; Gallagher et al., 2013; Harkness et al., 2011; Lee et al., 2013).   
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In the Harkness et al. (2011) study, 44 HF patients (mean age 76 +/- 6.6), NYHA 
Class I-IV, with no suspected or documented cognitive impairment, completed the 
MoCA. More than 70% scored below the MoCA cutoff score of 26. However, 91% of 
patients with NYHA Classes III-IV had a MoCA scored < 26, while 52% of patients with 
NYHA Class I-II scored below 26 (p = 0.004). Cognitive domain sub-scores showing 
significant differences were short-term memory, visuospatial function, executive 
function, and language (p < 0.01). The Montreal Cognitive Assessment tool was used to 
study 128 HF participants in which it was found that 22% were classified as impaired, 
scoring < 22 on the MoCA (M 80.65 years) in the domains of delayed recall, 
visuospatial/executive function and abstraction (Gallagher, et al., 2013).  In a study 
examining whether impairment in certain cognitive abilities could predict self-care ability 
in patients with systolic impairment, 148 stable HF outpatients completed the Montreal 
Cognitive Assessment (MoCA) tool, which measures short term verbal memory recall, 
visuospatial ability, executive function (organizing, sequencing, problem-solving, math 
calculation), attention, concentration, working memory, language, and orientation (Lee et 
al., 2013). The results showed that 14.2% of the participants scored lower than 24 on the 
MoCA. They reported 21.5% worse self-care scores (European HF Self-care Behavior 
Scale-9) than the participants whose MoCA scores were > 24 (p = .014) and 51% worse 
consulting behaviors (p < .001).  
The Mini Mental State Exam (MMSE) is an exam that was originally developed 
to quantify cognitive impairment and to attempt to differentiate organic from psychiatric 
etiologies (Folstein et al., 1975). It has proved extremely useful since its inception to 
diagnose cognitive impairment, including dementia. A literature review for this study 
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found that in one study, comparing the MMSE and MoCA provided equivocal results 
(Godefroy et al., 2011), but in others, the MMSE was not sensitive enough to quantify 
deficits in Executive Dysfunction (Dong et al., 2010; Kaufer et al., 2008; Luis et al., 
2009; Pendlebury et al., 2011; Serber et al., 2008; Watson et al., 1993; Woo et al., 2009).  
Athilingam et al., (2011) enrolled 90 community dwelling adults with HF aged 
50-89 years (mean 62, SD 9) and administered both the MMSE and MoCA. Most (77%) 
had systolic HF as evidenced by an ejection fraction of < 40%. Among the participants, 
54% scored < 26 on the MoCA, while only 2.2% scored below 24 on the MMSE, yet was 
not statistically significant (χ2[1] = .348, p = .49). The mean MoCA score was 24.86 (SD 
2.81), while the mean MMSE was 28.96 (SD 1.66). The authors felt that part of the 
reason their study failed to show statistical significance on the score difference might 
have been due to a predominance of NYHA Class II patients who had less cognitive 
impairment. Class III-IV patients enrolled in fewer numbers due to feeling fatigued. 
Additionally, the cardiology services at their institution utilized the services of advanced-
practice nurses using a transitional-care model and cardiologists with disease-specific 
competencies. The authors felt that these attributes may have resulted in improved patient 
outcomes and reduced use of resources. Therefore, the results possibly do not represent 
all community-dwelling individuals with HF who may have been unable to seek care at a 
University Medical Center with up-to-date HF services. 
Pendlebury et al. (2011) tested 413 patients with transient ischemic attack and 
stroke. It was found that both the MMSE and MoCA were highly correlated (r2 = 0.80), 
but that the MMSE scores were more skewed than the MoCA, which were more normally 
distributed. From that sample, 291 (70%) had a MoCA score of < 26 /30, while 162 had 
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an MMSE of ≥ 27/30. On the other hand, only 5 patients had a MoCA ≥ 26 when the 
MMSE was < 27 (p < .0001). Additionally, in patients with an MMSE ≥ 27 and the 
MoCA < 26, the patients had higher Rankin scores (p = .0003), indicating greater 
functional disability and had deficits in delayed recall, abstraction, visuospatial/executive 
function, and sustained attention. These results demonstrate that the MMSE demonstrated 
scores within an acceptable normal range, when in fact there were measurable cognitive 
deficits that would impact a patient’s ability to care for themselves. 
Still comparing the MoCA and the MMSE, 100 post-mild stroke patients without 
significant physical disability, dysarthria, aphasia, or pre-existing dementia were 
evaluated using the MMSE and MoCA (Dong et al., 2010). Fifty-seven patients had 
normal MMSE scores (> 24). Of those 57, 18 (32%) had MoCA scores < 21, which was 
the definition of impairment in this study. In contrast, only 2 out of the 41 with 
unimpaired MoCA scores had impaired MMSE scores. The cut-off of 21 in the MoCA 
was determined by the sensitivity and specificity statistics. At 21/22, the MoCA had a 
sensitivity of 90.3%, and a specificity of 76.8%. The lower the score, the less sensitive 
the test became, but the specificity improved. The same rational for the sensitivity and 
specificity of the MMSE cutoff score of 24 (85.5%/82.1%) (Dong et al, 2010). Dong et 
al. (2010) postulated that the weakness in the MMSE is the absence of visuospatial, 
executive function, and abstract reasoning tests.   
Many of the therapies, such as taking many medications throughout the day and 
following a low-sodium diet and fluid restriction, require utilization of the cognitive 
skills of planning, organizing, and sequencing in order to successfully adhere to the 
program. These executive functions are not readily apparent in patients on a day-to-day 
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basis, so many patients, apparently cognitively intact, are discharged to home with the 
usual discharge instructions, only to return in a few short weeks with acute exacerbation 
of HF and a marked lack of understanding about how that happened (Miller & Shaper, 
2015; Ogren, Fonarow, & Woo, 2014; Paul & Hice, 2014; Pressler et al., 2010).  
Recent research has begun to document the presence of mild cognitive 
impairment in HF patients, particularly in the areas of executive function. Therefore, 
assessing cognitive function by discharge from an acute care facility would be an 
important part of discharge planning, as these patients, and their families, may need 
additional support in the home to follow these HF therapies. The search for a rapid, 
accurate, ease-of-administration cognitive assessment tool is underway, with most of the 
published research comparing various tools to the MMSE. However, as described above, 
the MMSE is frequently unable to test for delayed recall, abstraction, visuospatial and 
executive function. As a result of this mounting evidence, the MMSE will not be used in 
this study to quantify cognitive function, but rather the MoCA (Appendix C) will be used 
to screen for cognitive function. This study will attempt to bridge the gap in knowledge 
and practice concerning assessment of cognition and the impact of cognitive function on 
change in weight in HF patients. 
Change in Weight. 
According to Gibson (2005), “Body weight is the sum of the protein, fat, water, 
and bone mass in the body” (p. 257). Since fat contains essentially no water, the 
remaining components, protein, bone mass and water, the “fat free” mass, are 73% water 
(range of 67% to 77%) in healthy individuals (Gibson, 2005). In steady state individuals, 
fat mass remains relatively constant, so any fluctuations in body weight in a one-to-five 
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day period would be related to fluid fluctuations, not fat (Heymsfield & Baumgartner, 
2006; Konishi et al., 2009). Body weight is considered to be that weight where the 
cardiac output for an individual is maximized, and evidence of excessive fluid 
accumulation in the lungs, abdomen and extremities is not present (Lindenfeld et al., 
2010). For this reason, and to maintain body weight, HF patients are prescribed a fluid 
restriction of 1.5 – 2 Liters per day from all sources (Gruszczynski et al., 2010; Guglin, 
2011; Lindenfeld et al., 2010). 
Research studies have shown that many HF patients do not weight themselves 
daily to monitor for weight gain (Howlett, 2011; Moser, Doering, & Chung, 2005; 
Riegel, Dickson, Goldberg, & Deatrick, 2007). Two hundred two patients with Class III-
IV HF, recently discharged from the hospital within 3-7 days, were assessed on many 
physiologic, functional and psychological variables, including adherence to several self-
care attributes (Moser et al., 2005). These attributes included adherence to medications, 
low-sodium diet, daily weights, and symptom monitoring. It was found that only 14% of 
these patients weighed themselves daily (Moser et al., 2005). 
Preventable causes of hospital admissions for decompensated HF were examined 
in a quantitative study where 179 HF patients (mean age 75.4 years; 88.1% were New 
York Heart Association [NYHA] Class II or IV) were interviewed about medications, 
diet, sodium intake, fluid management, and daily weights (Michalsen et al., 1998). Of 
these patients, 75% reported taking their drugs intermittently. Daily fluid intake could 
only be estimated in 92.2% of the patients and of those, 34% consumed more than 2.5 
liters per day. Only 26.3% of patients were aware of the need for fluid restriction or paid 
attention to their daily fluid intake. Only 38.2% of patients weighed themselves regularly, 
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even though 86.6% of patients had scales at home. Lack of correlation between 
knowledge and adherence was also found in this study. Overall, it was found that 41.9% 
of causes of acute decompensation in this population were due to non-adherence to drugs 
or diet. 
Konishi et al. (2009) examined the clinical characteristics of 194 patients admitted 
for acute decompensated HF. It was noted that some patients had a rapid onset of 
symptoms of dyspnea with more pulmonary congestion, while others had a slower onset, 
occurring over several days which was also associated with peripheral edema to a greater 
extent (p < .001). An analysis of these two groups showed that the rapid on-set group was 
associated with excessive water intake (80%), whereas the gradual progression had a 
lower proportion of patients who consumed excess water (32%) (p < 0.001). 
Unfortunately, the amount of weight lost during the hospitalization, which would be a 
measure of the amount of excess intravascular fluid (Francis & Tang, 2004), was not 
reported. The authors report that a weakness of this study was that it was a retrospective 
chart review, so precise quantification of the amount of water consumed was impossible. 
The definition of excess water consumption, a critical factor in the patients’ progression 
to acute decompensated HF was defined loosely as “…the consumption of more drinks 
than usual” (p. 304) (Francis & Tang, 2004). 
Weight Assessments. 
In a hemodynamically stable patient, the body weight will remain stable from day 
to day in the short term ± 2 lbs. (Lindenfeld et al., 2010; Moser & Riegel, 2004). In 
Riegel’s Situation-specific heart failure self-care theory, the ability of the patient to 
maintain this stability is called weight maintenance. Patients with HF who are beginning 
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to retain fluid volume, will typically demonstrate an increase in weight (Francis & Tang, 
2004). An overnight change of weight of > 1 lb. as measured by simple bathroom scales 
would not be fat accumulation, but rather water weight (Jessup & McCauley, 2003; 
Miller & Mullan, 2014; Moser & Riegel, 2004).  
The importance of helping patients understand the need to weigh themselves 
daily, to assess the significance of any weight gain, to implement a treatment regimen, 
and to evaluate its effectiveness cannot be overstated. Patients must be engaged in their 
own self-care and must have the cognitive skills to engage in these self-care behaviors. It 
has been demonstrated that a significant number of patients do not weigh themselves 
daily, let alone assess significance, implement a treatment, or evaluate its effectiveness. 
Little research has been done to document weight maintenance in this population, 
although weight maintenance is critical in the management of this chronic condition.   
Depression. 
 It is becoming well documented that individuals with HF have a significant 
incidence of depression (Alosco, et al., 2013; de Jonge et al., 2006; Faller et al., 2011; 
Frasure-Smith et al., 2009; Heo, Moser, Pressler, Dunbar, Dekker, and Lennie, 2014; 
Nabi et al., 2010; O'Connor et al., 2010; Ogren et al., 2014; Pressler et al., 2010; 
Rutledge, Reis, Linke, Greenberg, and Mills, 2006; Stewart, Fitzgerald, & Kamarck, 
2010; Tang, Yu, & Yeh, 2010; Thombs et al., 2010; Tousoulis et al., 2010; Turvey, 
Schultz, Arndt, Wallace, & Herzog, 2002; Woo et al., 2009). While the occurrence of 
depression in the general population has been estimated to be around 7% (Compton, 
Conway, Stinson, & Grant, 2006), 22% (Ogren et al., 2014), and 40% (Tousoulis et al., 
2010), depression in the cardiovascular population has been variously measured to be 
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anywhere from 10% (de Jonge et al., 2006) to 31% (Heo, et al., 2014) and 42% in Class 
IV patients (Rutledge, Reis, Linke, Greenberg, & Mills, 2006).  
 Rutledge et al. (2006) did a meta-analysis of existing literature prior to 2006 and 
put the number of depressed HF patients at 21.5% of all HF patients, but doubling that 
rate among patients with more severe HF (Rutledge et al., 2006). Rutledge (2006) did not 
specify whether patients being studied were in-patients or out-patients due to the fact that 
they were reviewing 36 articles that studied depression in HF patients. Some articles 
discussed changes in depression in follow-up after being hospitalized for treatment. 
Whether that hospitalization was for treatment of HF or for depression is unclear. For 
hospitalized HF patients, one study documented the prevalence of depression to be as 
high as 51% (Freedland et al., 2003).  
 It is documented that there are biologic mechanisms at work in HF patients that 
contribute to depression over and above a psychological unhappiness about having a 
terminal illness (Tousoulis et al., 2010). Depression in HF patients has been attributed to 
impaired function of monoamine adrenergic neural receptors, increased activity of the 
rennin-angiotensin-aldosterone system as well as the hypothalamus resulting in increased 
circulating glucocorticoids (Ogren et al., 2014). There are also alterations in the 
autonomic nervous system, chronic systemic inflammatory process mediated by 
cytokines, and increased serotonin levels and catecholamine levels (Ogren et al., 2014).  
 Transcranial doppler (TCD) ultrasonography was employed to assess cerebral 
blood flow velocity and compared to scores on the BDI-II in 89 outpatients with NYHA 
Class II-III HF (M = 67.61, s.d 11.78 years; 73% male) (Alosco et al., 2013). On the 
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basis of established cut-off scores for the BDI-II, 15.7% of the participants exhibited 
mild, moderate and severe depressive symptoms. 
 Coupled with those biologic factors are psychologic factors related to feelings 
about reduced ability to exercise, increased fatigue, decreased ability to engage in usual 
self-care activities and minimal social support systems (Tousoulis et al., 2010). It has 
been demonstrated that the experience of depression is more severe in patients with 
NYHA Class IV than Class I, quite possibly related to worsening dyspnea and fatigue 
(Freedland et al., 2003 (Ogren et al., 2014; Rutledge et al., 2006; Tousoulis et al., 2010). 
Freedland et al (2003) administered the Beck Depression Inventory (DPI) to 613 
hospitalized patients (age >40, 50.5% female, 61.7% Caucasian) and found that while 
51% scored ≥ 10, thus meeting the DPI criteria for some level of depression, it was found 
that evidence of depression varied widely depending on age (< 60 vs. > 60), male vs. 
female, NYHA classification IV > I, and whether there were certain comorbidities such 
as COPD, sleep apnea, or history of depression. In a study examining depression 
following myocardial infarction, de Jonge et al (2006) found that 216 out of 1, 972 
patients (10.9%) met the diagnosis of clinical depression according to ICD-10 criteria. 
Frasure-Smith et al. (2009), examined 974 HF patients (66 ± 11 years of age; 17.7% 
women) with atrial fibrillation from ten countries using the Beck II Depression Inventory 
(BDI-II). Overall, 32% had BDI-II scores ≥ 14 (mild to mod symptoms of depression) (p 
= .001). In a study examining whether depression predicted coronary heart disease and 
cerebrovascular disease, 23,282 adults (9,507 men), aged 20-54 years were followed for 
seven years. Using the Beck Depression Inventory II, 19.6% of all participants scored ≥ 
10, indicative of depression (Nabi et al., 2010).  
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While examining the relationship between cognitive deficits and health related 
quality of life in 249 HF patients, Pressler et al. (2010) measured depressive symptoms 
using the Patient Health Questionnaire 8 (PHQ-8) and found the mean score was 6.5 
where a score above four was the cutoff for increasing degrees of depression. 
Specifically, 26% had moderate or high depressive symptoms because of PHQ-8 scores 
of ≥ 10 out of 24. Heo, Moser, Pressler, Dunbar, and Dekker (2014) documented that 
depressive symptoms in 145 HF patients were more prevalent in the presence of a high 
circulation of the inflammatory markers tumor necrosis factor (TNF), interleukin-6, and 
soluble TNF receptors I and II (F = 7.915, p = .005). 
One hundred seven participants (aged 42-89, mean 69.31), predominantly male 
(53.3%) were assessed for depression as part of a fatigue in HF study (Tang, et al., 2010). 
In this study, the BDI-II mean score, was 15.9 (SD 6.23), consistent with mild 
depression. Neither the number nor percent of the participants with depression in this 
study was reported. An early study, aimed at quantifying the prevalence of depressive 
symptoms in community dwelling patients with HF, used the Center for Epidemiologic 
Studies – Depression Scale (CES-D) with 6,125 people aged ≥ 70 years. The study 
revealed that 11 % of HF patients met criteria for depression, compared to 4.8% of 
patients with other cardiac diagnoses and only 3.2 % of those with no reported heart 
condition.  
In the research done on the brains of younger HF patients using MRI (Woo, et al., 
2009), it was found that the areas involved showing brain injury correlated with 
emotional lability, including depression. Three hundred six patients (82% Caucasian 
male) with coronary heart disease completed an Inventory to Diagnose Depression which 
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found that 8.6% met the DSM-II-R criteria for Major Depressive Disorder (Doerfler, 
Pbert, & DeCosimo, 1997). Neuroimaging was used by Vogels, Oosterman, Van Harten, 
Gouw, et al. (2007) to investigate the relationship between cerebral abnormalities 
detected by MRI and cognitive performance in 58 HF patients (mean age 68.7 ± 9.1 
years, 26% female, mean LVEF 27% ± 7.2) who did not have a previous diagnosis of 
dementia. Depression was also assessed and it was found that white matter 
hyperintensities were correlated with depression and anxiety scores (p < 0.05). 
Not all studies support the presence of significant depression in people with 
cardiovascular diseases other than HF. Stewart et al. (2010) studied the emotional risk 
factors for coronary artery disease of depression and hostility in 296 men and women 
aged 50-70 years over 6 years and found BDI-II mean scores of only 3.8 (± 3.9) at 
baseline and 5.1 (± 5.1) at the end of the study. In a study examining the effect of somatic 
complaints on 477 post-acute myocardial patients’ self-report of depression, the BDI-II 
scores were 9.2 (SD = 7.9) (Thombs et al., 2010). 
Clearly, there is evidence that results of studies may vary as described so well by 
Freedland et al. (2006) due to differences among studies as to age, gender, NYHA 
Classification, various depression measuring tools, and comorbidities. However, there is 
strong support for the occurrence of depression in HF patients that by many measures 
may exceed the occurrence of depression in the general population. 
Cognitive Impairment and Depression.  
A review of the literature reveals a growing body of research on the correlation of 
depression and cognitive impairment (Butters et al., 2004; Cameron et al., 2009; Clark & 
McDougall, 2006; Frasure-Smith et al., 2009; Meiner, 2011; Pullicino et al., 2008). 
49 
Cognitive function and weight in HF patients 
However, the correlation between the two is proving to be inconsistent. Turvey et al. 
(2002) examined the rates of depression in 6, 125 older patients (mean age 76 ± 6) using 
the CES-D, but also cognitive status using a Telephone Interview for Cognitive Status, 
which was modeled after the MMSE. It was found that the “   CES-D score, comorbid 
illness, physical and cognitive disability and fatigue … entirely accounted for the 
association between HF and depression” (p > .0001) (p. 2006). A study examining factors 
contributing to cognitive impairment in HF evaluated 14,089 participants of the Reasons 
for Geographic and Racial Differences in Stroke cohort (Pullicino et al., 2008). It was 
revealed that participants with HF were 1.51 times more likely to have cognitive 
impairment than those without HF (95% CI: 1.15-1.96). Cognitive impairment was found 
to be associated with depression (p < .0001). 
While examining the relationship between cognitive deficits and health related 
quality of life in 249 HF patients (mean age 62.9, SD 14.6; 63.5% male; 67 % white, 
31.7% African American), Pressler et al. (2010) measured cognitive status using the 
MMSE, the Wechsler Test of Adult Reading, the Boston Naming Test, the Digit Span, 
the Hopkins Verbal Learning Test, Figure Copy, Digit Symbol, Trail Making Test A & 
B, and the Controlled Oral Word Association Test. The sample included patients from all 
four NYHA Classes, 73% of which were Class II & III, with a mean ejection fraction of 
28.3 % (SD 10.2). In this study, 26% had moderate to high depressive symptoms and 
24% had cognitive deficits in three or more domains. Since this study was examining the 
relationship of cognitive deficits to Health Related Quality of life, a statistical 
relationship between cognitive deficits and depression was not reported.  
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Neuroimaging was used by Vogels, Oosterman, Van Harten, Gouw, et al. (2007) 
to investigate the relationship between cerebral abnormalities detected by MRI and 
cognitive performance in 58HF patients (mean age 68.7 ± 9.1 years, 26% female, mean 
LVEF 27% ± 7.2) who did not have a previous diagnosis of dementia. It was found that 
while memory and executive functions were associated with changes in the medial 
temporal lobe atrophy (MTA), depression was associated with changes in the total and 
deep white matter hyperintensities (WMH) and that cognition and depression were not 
statistically correlated. The authors concluded that this lack of correlation was compatible 
with other reports in the literature that were unable to demonstrate a consistent 
association between the two. 
Depression Assessments. 
Because of the inconsistencies in research demonstrating that the presence of 
depression may or may not impair cognition (Kinsinger, Lattie, & Mohr, 2010; Pullicino 
et al., 2008), it is necessary to document the presence or absence of depression in this HF 
population and to assess whether there is a difference in cognitive function scores on the 
MoCA between patients who have depression and patients who do not. Beck, Ward, 
Mendelson, Mock, and Erbaugh (1961) developed and tested what became known as the 
Beck Depression Inventory II. The Beck Depression Inventory II was chosen for this 
study (Appendix D), because it has a proven track record for screening for the presence 
of depression in cardiovascular patients (Frasure-Smith et al., 2009; Nabi et al., 2010; 
Stewart et al., 2010; Tang et al., 2010; Thombs et al., 2010).  
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Activities of Daily Living (ADL). 
With moderate to severe cognitive impairment, it may be noted that the individual 
may have difficulties completing basic care activities such as bathing and dressing 
(Meiner, 2011). It has been demonstrated that a patient’s ability to care for themselves 
and engage in activities of daily living correlates with cognitive function (Katz, S., 1983). 
The Katz Index of Activities of Daily Living (ADL) Tool (Katz, Downs, Cash, & Grotz, 
1970) (Appendix A) is a useful way of documenting the presence of impairments in 
function in the areas of bathing, dressing, toileting, transferring, continence, and feeding 
(Katz, S., 1983; Katz, et al., 1970; Meiner, 2011). This tool has been in use for four 
decades to document functional decline in the cognitively impaired, as well as in persons 
with disability (Chen & Kane, 2001; Graf, 2006; Katz, S., et al., 1970; Wallace & 
Shelkey, 2007). It is used by health care providers to plan for care in the acute care 
setting as well as in the community setting and to quantify decline in functional ability 
through repeated measures over time (Wallace & Shelkey, 2007).  
In a study examining functional outcomes in 214 community dwelling elders 
(mean age 77 years +/- 7), who required hospital admission for community-acquired 
pneumonia, exacerbations of chronic HF, chronic obstructive pulmonary disease 
(COPD), or cellulitis, 84 were treated in Hospital at Home (HaH) and 130 were treated in 
an acute care hospital (Leff et al., 2009). The Katz ADL tool was used to quantify the 
status of Activities of Daily Living from 1 month before admission to 2 weeks post-
admission in each group. In another study, the Katz ADL tool was used as a gold 
standard comparator to test a Short Physical Performance Battery (SPPB) to quantify 
functional status in a group of 92 women and men (49% women) ≥ 65 years of age (mean 
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age 77.7 years; range 65-94) who were able to walk and who were admitted to the 
hospital with HF, pneumonia, chronic obstructive pulmonary disease (COPD), or minor 
stroke (Volpato et al., 2008). The results of the positive correlations (-.45 on admission, p 
< .0001 and -.54 at discharge, p < .001) of the SPPB with the Katz ADL tool provided the 
first evidence of the utility of the SPPB for lower extremity physical function measures. 
Activities of Daily Living Assessments. 
Over the years, the Katz ADL tool has been modified or combined with the 
Lawton and Brody Instrumental Activities of Daily Living Tool (IADL) to meet the 
measurement needs for special populations. An example of this modification is apparent 
in a study examining the ADL’s of older persons in primary health care who have HF 
(Norberg, Boman, & Löfgren, 2008). In this study, the basic Katz ADL tool was 
extended to form the Staircase of ADL (11) and was used to identify and obtain an 
overview of the participants’ perceived dependencies in ADL activities. The assessment 
comprised five personal activities of daily life (bathing, dressing, toileting, transfer, and 
feeding), plus four instrumental activities of daily life (cleaning, shopping, transportation 
and cooking). Performance level on each item was ranked on a 3-point scale of 
independent, partly dependent or dependent. The modified tool (the Staircase of ADL 
[11]) was then used to quantify the ADL-ability of older people with CHF syndrome. 
Forty persons > 65years of age (mean age 81) with NYHA Class I-IV HF participated. 
Participants who were Class III/IV had significantly increased effort when performing 
ADL-tasks (OR: 15.5, CI 2.40-100.1, p = 0.004) compared to those in NYHA Class I/II.  
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Instrumental Activities of Daily Living (IADL). 
When cognitive impairment presents as short term memory loss, difficulty 
organizing and sequencing, and problem solving, it may be noted that the individual is 
also having difficulties completing more complex tasks such as using a telephone, 
shopping for oneself, preparing food using multiple steps, banking, and doing 
housekeeping (Graf, 2006; Katz, S., 1983; Lawton & Brody, 1969; Meiner, 2011). 
Lawton and Brody (1969) developed a tool called the Instrumental Activities of Daily 
Living Tool (IADL) (Appendix B) to quantify the ability of individuals to care for 
themselves in those domains as well as laundry, transportation, self-medication, and 
handling finances. This tool is used by health care providers to plan for care in the 
community setting and to quantify decline in functional ability through repeated 
measures over time (Graf, 2007). In this study, the IADL’s tool will be used to document 
this more advanced functional status. This tool is different from the ADL tool by Katz 
because it measures behavior that requires more complex cognitive skills (Katz, S., 1983; 
Lawton & Brody, 1969).  
The IADL tool was used in a study examining the effects of using consumer and 
expert ratings of an activities of daily living scale to predict functional outcomes of 
patients hospitalized for stroke HF, COPD, hip fracture and hip replacement (Chen & 
Kane, 2001). In this study, another tool had been developed based on both the ADL and 
IADL and was being tested in these special populations. Leff et al. (2009) used the IADL 
tool in a study comparing functional outcomes of 214 community dwelling elders who 
required hospital admission for pneumonia, HF, or COPD. Eighty-four were treated in a 
Hospital at Home (HaH) situation and 130 were treated in a traditional acute care 
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hospital. Measurements included a change in the IADL scores from 1 month before 
admission to 2 weeks post admission to HaH or acute hospital. Volpato et al. (2008) used 
the IADL as a gold standard against which to compare of the Short Physical Performance 
Battery (SBBP) in 92 older patients (mean age 77.7 years; range 65-94), who were 
admitted to the hospital with HF, pneumonia, COPD, or minor stroke. The SBBP was 
judged to be of future utility in the assessment of lower extremity physical function 
measures when it correlated with the IADL (-0.51, p < 0.001 on admission and -0.51, p < 
0.001 at discharge). 
In a study examining whether cognitive impairment contributes to limitations in 
instrumental activities of daily living, the Lawton and Brody IADL tool was used 
(McLennan et al., 2010). Two hundred nineteen patients with HF and diabetes were 
recruited from outpatient clinics. The IADL was used to measure functional ability and 
the MoCA was used to quantify cognitive function. Greater independence was associated 
with younger age (rs = .35, p < .001) more years of education (rs = -.026, p < .001), fewer 
cardiovascular diseases (rs = 0.26, p < .001) and better cognitive performance (rs = -.27, p 
< .001).  
The IADL tool was used to document disability in a HF population of participants 
who were NYHA Class II-IV recruited from an outpatient clinic (Seo, Roberts, 
LaFramboise, Yates, & Yurkovich, 2011). The objective of this study was to identify 
factors that contributed to IADL disability. A convenience sample of 48 men and 53 
women (mean age, 59.5 years) revealed that 71% of the variance in IADL’s was 
explained by dypnea (B = .67), functional capacity (B = -.25) and age (B = .19).  
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Instrumental Activities of Daily Living Assessments. 
Studies such as those described above provide important information about the 
more complex activities of daily living and provide guidance to healthcare providers in 
developing plans of care to target those factors that contribute to disability. In this study, 
the Lawton & Brody IADL tool will be used to assess more advanced levels of daily 
functioning (Lawton & Brody, 1969). 
Summary  
HF is a complex disease requiring many therapies for treatment. Because of the 
importance of weight maintenance in this population, it is important to document whether 
HF patients can maintain their weight over six weeks, preventing an expensive < 30-day 
hospital readmission. Riegel’s Situation-specific heart failure self-care theory, will 
provide guidance for the theoretical approach to this issue.  
Weight maintenance is dependent on the HF patient’s ability to take all 
medications as prescribed, including multiple doses of diuretics, follow a low sodium diet 
and fluid restriction, weigh themselves daily and remember to call the health-care 
provider should their weight rise more than a couple of pounds above their discharge 
weight. Clearly, having intact cognitive function to plan, organize, sequence, and 
problem-solve is vitally important to maintain this regimen. Therefore, it would be useful 
to know whether cognitive function impacts changes in weight between discharge and the 
clinic follow-up appointment four to eight weeks later. It would also be critical to know 
whether diuretic dose adjustments make a difference in these weight changes in order to 
avoid expensive and debilitating re-hospitalizations. 
56 
Cognitive function and weight in HF patients 
Cognitive function in HF is infrequently measured, but is recently being identified 
as a predictor of mortality in HF patients (Pressler et al., 2010). Intact cognitive function 
is critical to a patient’s ability to follow the complex treatment plan required for 
maintaining maximal cardiac output and maintaining body weight. Patients with memory 
loss may not be able to remember instructions resulting in errors with medication 
administration and fluid consumption resulting in increased weight and fluid shifts to the 
lung tissue. Health care providers, as well as family members may not be aware of early 
memory loss and difficulties with organizing, sequencing, complex reasoning and 
problem-solving skills. Therefore, patients with HF should be routinely assessed for 
impairments in these cognitive skills.  
There are a large number of clinical tests used to measure cognitive function. The 
MMSE has been used in many studies (Conn, Taylor, & Miller, 1994; Gravely & 
Oseasohn, 1991; Naylor, Stephens, Bowles, & Bixby, 2005; Serber et al., 2008) to 
document the presence of cognitive impairment, but it has been documented to not be 
sensitive enough to capture early cognitive decline or impairments in Executive Function 
(Serber et al., 2008; Watson et al., 1993; Woo et al., 2009). However, the MoCA 
screening tool has been shown to test for Executive Function (Dong et al., 2010; 
McLennan et al., 2010; Nasreddine et al., 2005), so was used to document cognitive 
function in this study. Depression has been inconsistently shown to influence cognition 
while functional status has been shown to have a positive correlation with cognition and 
are frequently used as surrogate markers for cognition. Therefore depression and 
functional status was examined in this study in order to explore their influence on 
cognitive function.  Since the HF nurses provide a variety of interventions, including use 
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of additional diuretics to the participants after discharge in order to prevent readmissions, 
the number of additional diuretics used to prevent weight gain, was also tracked. As a 
result, the foregoing literature review of critical variables provided the underpinnings for 
examining whether there was a difference in weight change over time in those HF 
patients who scored low versus high on a cognitive assessment tool. The literature review 
also provided support for whether there was a difference in weight change over time in 
those HF patients who had a low number of diuretic dose adjustments versus a high 
number of diuretic dose adjustments when followed in the clinic one to two months after 
discharge from the hospital for an acute exacerbated HF admission. 
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Chapter 3: Design and Methodology 
Research Design 
The impact of cognitive function on change in body weight in HF patients was 
investigated using an observational, longitudinal, descriptive design. The main research 
variables in this study were cognitive function and change in weight. Change in weight 
was the difference in weight between discharge (T1) and six-week follow-up (T2) (+/- 2 
weeks). Secondary variables known to impact cognitive function and body weight were 
measured in this study and included functional status (activities of daily living and 
instrumental activities of daily living) and depression. The number of times diuretic 
dosing was adjusted was also tracked. 
Figure 3 Research Design  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample and setting 
The participants were recruited using a convenience sample from the inpatient 
practices of three HF cardiologists at Penn Presbyterian Medical Center, a local 
Community Hospitalization 
Demographic Data 
-Gender, age, race;  
-marital status; insurance 
-Educational level 
- NYHA Class, adm & d/c 
-Medications 
-Co-morbid diseases 
Hospitalization with 
dx Acute 
Exacerbated HF 
Demographic Data 
-NYHA Class 
-Medications 
-Interim hospitalizations or  
-ER visits 
-# diuretic adjustments 
Enrollment – T1 
 
MoCA 
ADL/IADL 
Beck Depression Inventory 
Weights 
First post-discharge visit 
6 +/- 2 weeks after D/C – T2 
 
MoCA 
ADL/IADL 
Beck Depression Inventory 
Weights 
59 
Cognitive function and weight in HF patients 
University-affiliated Medical Center, admitted for acute exacerbation of HF. Penn 
Presbyterian Medical Center is a regional referral center for cardiac care, drawing 
patients from across southern New Jersey, as well as from the surrounding community in 
Philadelphia. The Inclusion/Exclusion criteria were defined as the following: 
Inclusion Criteria: 
1. The participants had to be hospitalized with a diagnosis of acute exacerbation of 
HF with systolic dysfunction (HFrEF). 
2. The Left Ventricular Ejection Fraction had to be ≤ 40% within the previous 
twelve months. 
3. The participants had to speak and read English and had to sign an Informed 
Consent prior to any study procedures being performed. 
Exclusion Criteria:  
1. The participants could not be receiving dialysis at the time of potential enrollment 
because the electrolyte shifts and varying fluid balances are known to alter 
cognitive functioning (Muwaswes, 1993)  
2. The participants could not have a history of severely diminished functional 
capacity or severe dementia necessitating full-time care, including nursing home 
patients admitted to the hospital as the care provider would have been providing 
all prescribed therapies or would have been ensuring that all medical therapies 
were followed. 
3. The participants could not have had a diagnosis of active psychosis because the 
responses to the study tests may not have been reliable and valid (Muwaswes, 
1993). 
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4. The participants could not have been pregnant due to the increase in baseline 
volume status associated with pregnancy which would result in exacerbation of 
HF (Elkayam & Gleicher, 1998). 
5. The participants could not have had an MI within the last 6 months due to the 
altered cardiac and psychologic function after the MI which could have impaired 
cognitive functioning (Thombs et al., 2010; Watkins et al., 2003). 
6. The participants could not have been using street or recreational drugs, or drink 
more than 4 alcoholic beverages per day per patient report due to the known 
impact that such substances have on cognitive functioning (Muwaswes, 1993). 
7. There were no racial, ethnic, or gender exclusion criteria in order to ensure an 
ethically just inclusion of a wide variety of people with HF, more representative 
of the larger population of people with HF. 
Sample Size Estimation  
Originally, a power analysis for a regression analysis was anticipated based on an 
alpha of .05, a Power of 0.80 and a moderate effect size R2 = 0.13, which resulted in the 
need for 77 participants (Munro, 2005). However, after 12 months of almost daily 
screening, only 30 participants signed consent forms and only 21 were suitable for data 
analysis due to deaths, withdrawal of consent, lost to follow-up, and meeting exclusion 
criteria. Therefore, as a result of the sample size, it was decided to examine the difference 
between baseline mean cognitive function MoCA scores and mean change in weight 
between T1 to T2.  
An Independent t-test was considered, but we realized an a priori T-test requires 
64 participants in each group for a two-tailed test with an alpha of 0.05, a moderate effect 
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size of .50 and a power of .80 (Munro, 2005). Since there were only 21 participants in the 
entire sample, the study was underpowered to detect statistical significance. Instead, the 
results of this pilot study will inform future research in this area.  
Measures  
Cognitive Function: In order to screen for a variety of cognitive domains, 
including those domains operational in Executive Function, the Montreal Cognitive 
Assessment tool (MoCA) was used (Dong et al., 2010; McLennan et al., 2010; 
Nasreddine et al., 2005). The MoCA was used to measure cognitive function in short-
term memory (noun recall), Visuospatial abilities (clock-drawing task and 3-dimensional 
cube drawing), mental agility, organizing, planning, and sequencing (a short version of 
the Trail-making B task), ability to speak consonants clearly and repeat two complete 
sentences (phonetics), and a two-item verbal abstraction (Nasreddine et al., 2005). 
Attention, concentration, and working memory were evaluated using a sustained attention 
task with finger tapping, serial subtraction, picture naming, recalling words that begin 
with an “f,” and including orientation to time and place. The tool scores range from 0 to 
30, with a cut-off of 26 indicating possible cognitive impairment in non-cardiac patients 
(Nasreddine, et al., 2005).  
When the MoCA was developed, Nasreddine et al. (2005) compared the MMSE 
with the MoCA, and used a cutoff score of 26 for both tests. The MoCA demonstrated 
90% sensitivity in the participants with mild cognitive impairment and 100% in the 
participants with Alzheimer’s disease. However, the MMSE demonstrated a sensitivity of 
18% in the participants with mild cognitive impairment and 78% in the participants with 
Alzheimer’s Disease. Specificity was 100% with the MMSE and 87% for the MoCA. 
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Test-retest reliability data demonstrated a correlation of 0. 92, (p < .001). The internal 
consistency of the MoCA yielded a Cronback alpha of 0.83. It was found that the 73% of 
the patients with mild cognitive impairment scored in the normal range on the MMSE, 
but in the abnormal range on the MoCA. In other words, the MoCA was measuring 
executive dysfunction which the MMSE was missing.  
The MoCA was cross-validated between participants with Alzheimer’s disease 
and participants with mild cognitive impairment in a study by Luis, et al. (2009) in order 
to test sensitivity and specificity of the tool.  One hundred eighteen adults in the 
southeastern US were tested using a cut-off score of < 25. This cut-off score 
demonstrated that the MoCA was not specific to cognitive impairment at that cut point. 
Using the recommended cut-off score of 26, the MoCA detected 97% of those with 
cognitive impairment, but the specificity was only fair at 35%.  When the cut-off score 
was set at ≤ 23, the MoCA demonstrated improved sensitivity (96%) and specificity 
(95%) (Luis, Keegan, and Mullan, 2009). 
The above review of the comparisons of the MoCA and MMSE demonstrates 
better specificity on the part of the MoCA to visuospatial, executive function, and 
abstract reasoning. The addition of the trail-making test or digit symbol test was 
recommended to supplement the MMSE to improve its sensitivity to those domains 
(Dong, et al., 2010). The MoCA has the Trail-making and digit symbol test already 
incorporated, along with a Clock Drawing test and cube-copying drawing test, both of 
which test visuospatial and planning skills. The ability of patients to be able to perform 
self-care requires the above cognitive skills. In order to do math calculations related to a 
2 Liter fluid restriction, in order to remember to perform daily weights, in order to 
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problem-solve the meaning of a 2 lb. weight gain and know to call their cardiologist, the 
patients must have intact cognitive functioning. Therefore, the MoCA was used as a 
cognitive function measurement tool in this study with a score of 24 as the cut-off point 
to determine the presence or absence of cognitive impairment in HF patients (Cameron, 
Worrall-Carter, Riegel, Lo, and Stewart, 2009; Lee et al., 2013). 
In order to perform the MoCA test, the participant was asked to draw the dot-to-
dot, the cube, and the clock drawing directly on the paper form with a pencil, while the 
bottom half of the paper was covered up. Then the participant was shown the pictures of 
the animals and asked to name them. Afterward, the page was removed from the table 
and the rest of the testing was administered verbally by the researcher. The form was 
scored out of patient’s presence. 
Body Weight: The patient was weighed during the research study visit, prior to 
discharge (T1), using an Electronic 7544BL Cal-Max wide body, Glass Scale by Taylor 
(China) bathroom scale. The scale could weigh up to 440 pound in 0.2 pound increments 
and had a 15 inch wide 8 mm safety glass platform, wide enough for patient stability. The 
scale was calibrated prior to use by tapping quickly on the platform which had been 
placed on a hard surface. After the display turned on and off, the scale became ready for 
use.  The scale was transported to the patient in a brief case with shock absorbing 
padding to promote reliability in measurements among the patients.  
Change in weight was calculated from weights at T1 to weights at T2 on the 
dedicated research bathroom scales. Participants were divided into three groups based on 
change in weight: participants who lost more than two pounds by T2, participants who 
maintained ± 2 lbs. from their T1 weight, and participants who gained more than two 
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pounds by T2. The change in weight between the two time points was examined to see if 
the participant gained weight while in the home environment.  
Activities of Daily Living Tool. 
 The Activities of Daily Living Tool (ADL) (Katz et al., 1970) was used to 
quantify the ability of individuals to care for themselves in the domains of bathing, 
dressing, toileting, transferring, continence, and feeding ( Katz et al., 1970;). The 
maximum score was 6 (one point for each area), where 4 indicated moderate impairment 
and 2 indicated severe impairment in function. Administration time was about five 
minutes. Reliability and Validity statistics could not be found in a literature search, but 
this tool has been the gold standard over the last forty years for these specific 
measurements (Graf, 2006; Wallace & Shelkey, 2007).  
Instrumental of Activities of Daily Living Tool. 
 The Instrumental Activities of Daily Living Scale (IADL) (Lawton & Brody, 
1969) was used to quantify the ability of individuals to care for themselves in the 
domains of telephoning, shopping, food preparation, housekeeping, laundry, 
transportation, self-medication, and handling finances (Graf, 2006, 2007; Lawton & 
Brody, 1969). The maximum score is 8 with 8 considered to be high functioning for 
women and 5 considered to be high functioning for men due to the fact that culturally 
speaking, most men do not do food preparation, housekeeping and laundering even if 
they are able (Graf, 2007). A score of zero is considered to be the lowest level of 
functioning and is consistent with total dependency. Administration time is about 10-15 
minutes (Graf, 2007). This tool has been used for four decades to quantify functional 
status and has proven reliability and validity. 
65 
Cognitive function and weight in HF patients 
Reliability was tested originally with the Physical Self-Maintenance Scale 
(PSMS) and was .96 with an inter-rater reliability of .87-.91 (Lawton & Brody, 1969). 
The validity was established by correlation with the Physical Classification of physical 
health scale, the Mental Status Questionnaire, the Behavior and Adjustment scale and the 
PSMS. All correlations were significant at the .01 or .05 level (Lawton & Brody, 1969). 
Administration time was about 10-15 minutes (Graf, 2007).  
Depression: Beck Depression Inventory II. 
 The Beck Depression Inventory II (BDI-II) was chosen for this study, because it 
has proven to reliably screen for the presence of depression in cardiovascular patients 
(Beck, Ward, Mendelson, Mock, & Erbaugh, 1961; Frasure-Smith et al., 2009; Nabi et 
al., 2010; Stewart et al., 2010; Tang et al., 2010; Thombs et al., 2010; Watkins, et. al., 
2003). The BDI is an easily administered twenty-one-question Likert Scale tool. The 
scores range from zero to 63, with the higher score indicative of depressive symptoms. 
Scores ranging from 0-13 indicate minimal depression. Scores greater than 14 indicate 
mild to severe depression (Beck, Steer, & Brown, 1996).  
The reliability testing at its inception, using Kruskal-Wallis Non-parametric 
Analysis of Variance by Ranks, revealed a very high correlation at the .001 level for 
every category tested except for the weight loss category, which was significant at the .01 
level (Beck, Ward, Mendelson, Mock, and Erbaugh, 1961). Its reliability was measured 
by Reynolds and Gould (1981) and found to be .85. Reliability was tested by Kinsinger, 
et al. (2010) and found to highly correlate with the Hamilton Rating Scale for Depression 
(r = .71, p < .001). Validity of the instrument was established by its developers using the 
Kruskal-Wallis One-way Analysis of Variance by Ranks. For both the original group and 
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the replication group, the p-value of the differences between the means was < 0.001 
(Beck, et al., 1961). In using this tool, it must be kept in mind that it may test falsely 
positive for depression. For example, a positive reply on the “fatigue” item may be due 
only to the fatigue present in HF, not due to depression (Alosco et al., 2013; Heo et al., 
2014), although one study was found that found that removing the fatigue question from 
the BDI-II did not bias the association between depression and fatigue in patients with 
coronary artery disease (Bunevicius, Brozaitiene, Stankus, Bunevicius, 2011). 
Fluid Management Questions. 
 An important attribute of self-care management is the ability to know and follow 
a prescribed fluid restriction prescription provided by the cardiologist or nurse 
practitioner.  To document that data, participants were asked questions about the amount 
of fluid they were allowed to have, whether they followed the fluid prescription, and how 
much they consumed (Appendix E). In addition, they were asked whether they weighed 
themselves daily, and to describe how they kept track of how much fluid they consumed. 
Additionally, the participant was asked to report whether they had a fluid restriction prior 
to being admitted to the hospital and how much it was, their best estimate of whether they 
followed the fluid restriction and whether they weighed themselves daily. Also, they were 
asked to describe how they kept track of the number ounces of fluid they drank during the 
course of the day in real time (math calculations on paper, pitcher-pouring method, etc.). 
The participant’s chart was reviewed for the cardiologist’s prescription for the amount of 
fluid restriction. 
It was standard of practice with these HF cardiologists to have a nurse who is 
educated in the care of HF patients, to call the patients within 72 hours of discharge to 
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provide telephone follow-up including adjusting the number and dose of diuretics . This 
study tracked the number of diuretic dose adjustments that were made between discharge 
T1 and the clinic visit at T2.  
Demographic and Descriptive Variables. 
Demographic and descriptive data were obtained from the patient’s medical 
record during hospitalization and at follow up clinic, and through patient self-report. 
Demographic data included gender, age in years, race, marital status, 
occupation/retirement status, income, living status (alone or with someone), did a care 
provider come into the home to help with personal or health care related to the HF, 
educational level, length of time diagnosed with HF, and age at time of HF diagnosis.  
The medical chart was reviewed for clinical data, which included additional co-
morbid diseases, concurrent medications, and data from neurological and physical 
assessments done by the nurses and physicians. Vital signs (heart rate, respiratory rate, 
temperature, blood pressure, and daily weights) obtained by the nursing staff were 
recorded upon admission and at discharge. Results of right heart catheter measurements 
(if obtained) were recorded once daily while the right heart catheter was in place. Results 
of ordered chest X-rays, echocardiograms, and lab values (metabolic panel, B-natriuretic 
peptides, CBC, and LFT’s) were documented. NYHA classification (Hunt, et al., 2009, 
pg. e8) was obtained from the physician or Certified Nurse Practitioner (CRNP) 
according to the following guidelines: 
• patients may have symptoms of HF at rest (class IV),  
• on less-than-ordinary exertion (class III),  
• on ordinary exertion (class II), or  
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• only at levels of exertion that would limit normal individuals (class I). 
Procedures  
The participants were recruited from the clinical practices of three HF physicians 
at Penn Presbyterian Medical Center. The physicians identified patients from their 
practice who had been admitted to the hospital with an Acute Exacerbation of Heart 
Failure, including having no known or previously diagnosed cognitive or psychosocial 
impediments that would prevent them from participating in this study. 
Visit 1 (T1): The identified, eligible patients were approached in their hospital 
room at Penn Presbyterian Medical Center. After initial introduction to the study by the 
researcher, potential participants were given verbal and written instructions on the 
purpose and procedures of the study. Potential participants were reassured that they did 
not have to participate, would not lose any benefits to which they are otherwise entitled, 
and could withdraw from the study at any time. After signing an Informed Consent form 
(ICF), the participants were given their own copy of the ICF and a copy was placed in the 
participants’ chart.   
The study activities took place in the participant’s hospital room to allow the 
participant to have privacy. The participant was given the questionnaire containing the 
request for demographic data (or it was read to them and they provided the information 
verbally). The MoCA was administered as described above. The ADL’s, and the IADL’s 
were read to the participant. The participant responded to questions for demographic data 
not found in the chart. The participant then participated in the MoCA and responded to 
the ADL’s, the IADL’s and Beck Depression Scale (BDI) questionnaires. If the 
participant needed to, a moment of rest was inserted where needed. The patient was 
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weighed during the research study visit using an Electronic 7544BL Cal-Max wide body, 
Glass Scale by Taylor bathroom scale (Appendix F).  
Finally, the participant was queried regarding their fluid intake by using the Fluid 
Management questions (Appendix E). In order to document the number of ounces of fluid 
that the participant was restricted to, the chart was reviewed for the number of ounces of 
fluid restriction prescribed by the cardiologist. The participant’s New York Heart 
Association Classification was obtained from a review of the chart. The chart was 
reviewed for the patient’s daily weights, vital signs, right heart catheter readings (if 
applicable) and laboratory values as described above.  
Visit 2 (T2): The participant completed the T2 visit at 6 weeks (+/- 2 weeks) in the 
clinic at either Penn Presbyterian Medical Center or at a community-based outpatient 
clinic, Penn Cardiology in Cherry Hill. The study activities took place in an examination 
room in the clinic to allow the participant to have privacy. The participants were asked if 
there had been any adverse events, Emergency Room visits, or hospitalizations, since 
discharge. The remaining activities concerned the administration of the same 
questionnaires, weight, and review of the chart as at T1. 
Data Management  
The results of the tests and questionnaires were placed in an envelope marked 
with the participant’s code and then sealed. The data were placed in a locked file until 
entered into the data base and analyzed away from the clinical area. Data were coded and 
entered into Statistical Package for the Social Sciences 22.0 (IBM/SPSS). The database 
was maintained on a password protected computer. All identifiers were removed from the 
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questionnaires and will be kept in a locked file for six years after data were analysis and 
manuscripts submitted for publication. 
Data analysis  
Descriptive statistics for the characteristics of the HF population under study were 
performed. Alpha was set at 0.05. Variability was calculated for all variables. For 
categorical data, frequencies were calculated; for continuous variables, means were 
calculated. Paired T-tests were performed to examine for differences among of the main 
variables (MoCA, ADL’s, IADL’s, and BDI’s) at T1 and T2. 
The primary aim of this study was to explore whether weight changes differed 
based on the presence or absence of cognitive impairment at baseline in HF participants 
who were followed in the clinic one to two months after discharge from the hospital for 
an acute exacerbation of HF admission. In order to answer the Primary Research 
Question: Is there a difference in weight change over time in those HF patients with and 
without cognitive impairment?, an Independent T-test was performed using SPSS to 
analyze the difference between cognitive functioning at T1 (low versus high scores) and 
change in weight over time. The independent variable was cognition as measured by 
MoCA, and the dependent variable was change in weight from T1 to T2.  
The second aim was to explore whether functional status, depression, or NYHA 
Class in HF participants followed in the clinic one to two months after discharge from the 
hospital for an acute exacerbated HF admission differed according to baseline cognitive 
impairment. In order to examine the secondary research question: Is there a difference in 
functional status, depression, or NYHA Class at follow-up in those HF patients with and 
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without baseline cognitive impairment, the variables were examined for any differences 
between T1 and T2 using Independent T tests.  
The third aim of this study was to explore whether there was a difference in weight or 
baseline cognitive function in HF participants who received a high number or low 
number of diuretic dose adjustments one to two months after discharge from the hospital 
for an acute exacerbated HF admission. In order to answer the research question, Is there 
a difference in weight change over time in those HF patients who had a low number of 
diuretic dose adjustments versus a high number of diuretic dose adjustments when 
followed in the clinic one to two months after discharge from the hospital for an acute 
exacerbated HF admission? the variables were examined for any differences at T1 and at 
T2 using Independent T-Tests. This was accomplished by comparing the mean scores of 
the dependent variable, weight change, for two different groups of participants: those 
who had low or high numbers of diuretic dose adjustments.  In order to answer the 
research question Is there a difference in baseline cognitive status in those HF patients 
who had a low number of diuretic dose adjustments versus a high number of diuretic dose 
adjustments when followed in clinic one to two months after discharge? the variables 
were examined for any differences at T1 and T2 using Independent T-tests. This was 
accomplished by comparing the mean scores of the dependent variable, baseline 
cognitive function, for two different groups of participants: those who had low or high 
diuretic dose adjustments. Finally, the research scales and clinic scales were examined for 
correlation. 
Limitations  
There were several limitations to the study.  
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• Not enough participants were recruited to perform a regression analysis, 
but the difference in weight from T1 to T2 based on cognitive function 
using an Independent T-test was performed.  
• The population to be studied was recruited from one acute-care hospital 
leading to a homogenous mix of patients that may not be representative of 
the general population of HF patients.  
• The patients were managed by three HF cardiology specialists whose 
standard of practice may be different from the general population of 
cardiologists around the country. In the patient population seen at Penn 
Presbyterian Medical Center, a nurse called the patients within 72 hours 
after discharge to make phone assessments of the patients’ statuses, to 
educate the patients about meds, diet and daily weights, and to adjust 
diuretics and dosing. The presence of a specially educated HF nurse who 
managed the patients after discharge may not be typical for all HF 
practices. 
• Attempting to measure cognitive function, even with a valid screening too, 
was a limitation due to the multiple factors that influence cognition.  
• Accurately measuring body weight was a challenge, even with a dedicated 
bathroom scale due to the refusal by most patients to change out of their 
street clothes to wear a patient gown. 
• One participant was too exhausted to get on the scales and refused. 
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• One participant was so weak that assistance from another staff member 
and the participant’s walker was required to transition from the 
examination table to the scale. 
• The BDI-II measures fatigue as an attribute of depression, but fatigue is an 
attribute of heart failure, which may have biased the results of that tool. 
• Some patients declined to be in the study due to the use of questionnaires, 
of multiple questionnaires, waiting for a call from the spouse, wanting to 
visit with relatives, and not wanting to participate in research of any kind.  
• Some patients were too sick or overwhelmed with their diagnosis to 
consider being in a research study. 
Human Participants 
Risks. 
 The risks to the patient who participated in this study included the possibility of 
psychological distress at being approached by a stranger to participate in a study. There 
was the psychological risk of answering a number of questions related to demographic 
information followed by having to describe whether they follow a prescribed fluid 
management plan, and whether they weigh themselves daily. Finally, there may have 
been psychological distress while doing the MoCA examination due to not knowing if 
they were doing the test correctly and imagining that the researcher would pass judgment 
on them if not. 
Benefits. 
 There were no direct benefits to the participant for participating in this study. The 
participant may have had an indirect benefit of feeling that they were helping other 
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people or of research in general to discover new information by participating in this 
study. There was the slight possibility that the participant may have inferred that if fluid 
management was important enough to do research on, then it must be very important, 
possibly resulting in a change in behavior at home. 
Risk/Benefit Ratio. 
 The psychological distress that may have been experienced was not expected to 
be extreme or harmful to the participant in any way. The benefit to the future 
management of patients with HF and cognitive decline may be significant as a result of 
the study. Therefore, the Risk/Benefit Ratio was not expected to interfere with participant 
enrollment or the conduct of the study. 
Compensation. 
The patients were offered a $25.00 Visa gift card upon completion of both study 
visits. 
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Chapter 4: Results 
Overview of the Study 
The impact of baseline cognitive function on change in weight over time in HF 
(HF) patients was investigated using an observational, longitudinal, descriptive design. 
The main research variables in this study were cognitive function and change in weight. 
Cognitive function was measured using The Montreal Cognitive Assessment (MoCA) 
test (McLennan et al., 2010; Nasreddine et al., 2005). The change in weight between 
enrollment at T1 and follow-up with the participant’s HF specialist at T2 was calculated 
from participant weights taken on research scales that were dedicated to the study.  
Secondary variables known to be associated with cognitive function were 
measured in this study and included functional status (Katz Activities of Daily Living and 
Lawson’s Instrumental Activities of Daily Living) and depression (the Beck Depression 
Inventory II). The number of times diuretic doses were adjusted was also tracked from 
the participant’s medical record (Epic). 
Demographic characteristics at enrollment into the study  
 
A total of 380 patients were screened for enrollment from December, 2011 to 
January, 2013. Most participants eligible for screening did not fit the inclusion/exclusion 
criteria due to dialysis or admission for valve repair, etc. From this group, only 66 
qualified for enrollment and were approached to be in the study. Only 30 patients 
consented to be in the study for an enrollment rate of 45.45%. Refusals included mostly 
personal reasons or living too far away to return to the clinic. From this group of 30 
participants who signed consents, one person was dropped due to meeting exclusion 
criteria, two participants withdrew consent, two died of HF related complications, and 
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three were lost to follow-up. One person was treated as an outlier due to losing a large 
amount of weight in order to prepare for a possible transplant, leaving only 21 
participants for statistical analysis (Figure 1).  
Figure 4 Consort Diagram 
 
 
 
 
             
 
 
 
 
 
 
 
      
 
        
 
 
 
           
                
      
       
        
         
 
 
 
 
 
 
 
 
 
 
 
 
 
Enrollment 
380 patients assessed  
for eligibility 
314 excluded 
271 did not meet inclusion 
criteria 
  
66 patients eligible 
 
30 patients enrolled 
2 participants withdrew consent 
1 participant withdrawn d/t exclusion 
criteria 
3 lost to follow-up 
2 died prior to visit T2 
1 excluded from data analysis as outlier 
Final sample: 
N = 21 participants 
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Demographic characteristics of the study sample at enrollment (N=21) are 
provided in Table 1. The average age of the sample was 67.10 years (SD 12.2; median 
68.00 ± 12.2), though participants ranged in age from 43-88 years. The sample was 
English-speaking, primarily male (76.2%), married (52.4%), Caucasian (81%), retired 
(47.6%), had at least a high school education (85.7%), and reported living with someone 
(71.4%).  
Table 1 Characteristics of Study Participants at Enrollment 
Variable        Value 
Demographics @ enrollment 
Age, Mean ± SD       67.1 ± 12.2 
Male, n (%)       16 (76.2%) 
Caucasian, n (%)       17 (81.0%) 
Married, n (%)       11 (52.4%) 
Lives alone, n (%)         6 (28.6%) 
 
Education, years, M ± SD @ enrollment             13.38 ± 3.2  
<12, n (%)          3 (14.3%) 
12, n (%)           9 (42.9%) 
>12, n (%)          9 (42.8%) 
 
Employment status 
Retired, n (%)       10 (47.6%) 
Employed/self-employed, n (%)       8 (38.1%) 
Disabled due to HF, n (%)        3 (14.3%) 
 
Financial status, M ± SD @ enrollment          $40,800 ± 28,659.40 
$0 to $25,000, n (%)        8 (44.4%) 
$26,000 to $50, 000, n (%)        6 (33.4%) 
$51,000 to %100,000, n (%)       4 (22.2%) 
 
At the follow-up visit, more participants reported having a caregiver at T2 (Table 
2) than at T1. Two participants reported that caregiver was a child (9.5%), one reported 
having some unpaid help (unspecified), eight participants reported having paid help 
(38.1%), which was for the purpose of assistance with bathing or with changing dressings 
due to having Milrinone infusions. The number of paid health caregivers was 
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significantly different from T1 to T2 (p =.04) as participants who had paid help were also 
on Milrinone infusions at home.  
Table 2 Characteristics of Study Patients: Caregivers, T1 to T2 
Variable    T1          T2  Fisher’s Exact X2 
          2-sided 
Caregiver           4 (19.04%) 10 (47.61%)  .04 
Child, n (%)         1 (  4.8%)   2 (   9.5%)  .10 
Unpaid Help, n (%)        1 (  4.8%)   1 (   4.8%)  .05 
Paid Help, n (%)         3 (14.3%)   8 (38.1%)  .04 
 
Clinical Characteristics 
Clinical characteristics of the study sample (n = 21) are displayed in Table 3. The 
mean length of time since diagnosis with HF was 12.4 years (SD 10.47; median 10.00 ± 
10.47 years) where the range was 0.03 years (new diagnosis 11 days prior to enrollment) 
to 43 years. The age of the participants at time of dx with HF was 0 years (newborn 
congenital heart disease) to 78 years of age (M 54.57 years of age, SD 16.34). More than 
half of the participants (71.4%, n=15) had ejection fractions between 10 and 20%. All of 
the participants in this sample had a diagnosis of cardiomyopathy (see Table 3). 
Table 3 Heart Failure Clinical Characteristics of Study Participants 
Characteristic         Value, n(%) 
Age at time of dx with HF, M ± SD                54.57 ± 16.34 
Time diagnosed with HF, years, Mean ± SD               12.40 ± 10.47 
0 to 5 years, n (%)          6 (28.6%) 
6 to 10 years, n (%)         6 (28.6%) 
11 to 20 years, n (%)         5 (23.6%) 
> 20 years, n (%)          4 (19.0%) 
Ejection Fraction @ enrollment 
10 to 25%, n (%)         18 (85.7%) 
30 to 40 %, n (%)           3 (14.3%) 
Type of Cardiomyopathy 
Ischemic Cardiomyopathy, n (%)       12 (57.1%) 
Non-ischemic Cardiomyopathy, n (%)        5 (23.80%) 
Congenital Heart Disease, n (%)         1 (  4.8%) 
Hypertensive CM/Dilated, n (%)         1 (  4.8%) 
No mention of etiology, n (%)         2 (  9.5%) 
79 
Cognitive function and weight in HF patients 
The participants in this study were admitted to the hospital for acute exacerbation 
of HF.  Of the 21 participants who completed visit 2, only 20 participants had their 
NYHA Classification documented.  Therefore, the discussion in this paragraph of NYHA 
Class is based on 20 participants who completed both Visit 1 and Visit 2. At admission to 
the hospital, 15.0% (n = 3) were classified as New York Heart Association Class II, 
40.0% (n = 8) were Class III, and 45.0% (n = 9) were Class IV based on presenting 
symptoms. 
Table 4 shows that the change in NYHA Classification from Visit 1 to Visit 2 was 
significantly different; none of the participants had a worsening of their HF classification 
from T1 to T2 (Fisher’s Exact Test = 12.8, p = .003). In this sample, there were nine 
participants who were classified as NYHA Class IV on admission to the hospital. Two of 
those nine dropped to Class III and one dropped to Class II. Additionally, there were 
eight participants who were classified as NYHA Class III during their hospitalization, 
and three dropped to Class II by Visit 2.  
Table 4 NYHA Classification at T1 and T2 - Crosstabulation 
 NYHA Classification at visit T2 
        II                      III                 IV 
NYHA Classification on admission T1      II                  3                       0                    0 
                                                                   III                 3                       5                    0 
                                                                   IV                 1                       2                    6 
 
 
Comorbid conditions at baseline are displayed in Table 5. The five most common 
comorbid conditions were chronic renal failure (76.2%), hypertension (71.4%), 
pulmonary hypertension (57.1%), hyperlipidemia (52.4%) and diabetes mellitus (52.4%). 
More than half of the participants presented with shortness of breath (57.1%), or dyspnea 
Fisher’s Exact Test = 12.8, p = .003 
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on exertion (DOE) (57.6%), see Table 5 for the variety of clinical presentations on 
admission to the hospital.  
Table 5 Comorbid Conditions at Baseline of Study Participants 
Comorbid Condition, T1               n (%) 
Chronic Renal Insufficiency     16 (76.2%) 
Hypertension       15 (71.4%) 
Pulmonary Hypertension     12 (57.1%) 
Hyperlipidemia      11 (52.4%) 
Diabetes Mellitus      11 (52.4%) 
Sleep Apnea/Obstructive Sleep Apnea     8 (38.1%) 
Gout          8 (38.1%) 
Anemia         7 (33.3%) 
CABG          6 (28,6%) 
Coronary Artery Stent       6 (28.6%) 
Obesity         6 (28.6%) 
Depression (under treatment)       6 (28.6%) 
Cancer of any kind        6 (28.6%) 
COPD          5 (23.80%) 
History of MI         4 (19.0%) 
CVA/TIA History        4 (19.0%) 
GERD          3 (14.3%) 
Hypothyroidism        3 (14.3%) 
Interstitial Lung Disease       1 (  4.8%) 
Arthritis         1 (  4.8%) 
Autoimmune Disorders       1 (  4.8%) 
Hospitalization Admitting Symptoms, T1      n (       %) 
Shortness of Breath (SOB)     12 (57.1%) 
Dyspnea on Exertion (DOE)     10 (47.6%) 
Swelling/Edema        9 (42.9%) 
Fatigue         9 (42.9%) 
Paroxysmal Nocturnal Dyspnea (PND)     6 (28.6%) 
Weight Gain         6 (28.6%) 
Ascites/Bloating        3 (14.3%) 
Orthopnea         2 (  9.5%) 
Angina         1 (  4.8%) 
 
Outcomes for these participants by Visit 2 (Table 6) included insertion of a 
ventricular assist device (VAD) (n = 3) and re-hospitalization for HF (n = 5). In this 
sample of 21 HF patients, five participants (23.80%) were re-hospitalized prior to Visit 
#2. Four were re-hospitalized for treatment of HF and one for treatment of dysrhythmias. 
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One person was treated in the Emergency Room for a gouty attack. Of the five people 
who were hospitalized, four were African American (MoCA < 24); the remaining 
participant scored ≥ 24 on the MoCA.  While four scored < 24 on the MoCA, it was not 
statistically significant (not rehospitalized: n = 16, MoCA score, M = 24.88, SD 3.7; 
rehospitalized: n = 5, MoCA score, M = 21.60, SD 2.97; t(df19) = 1.80, p = .09).  
Table 6 Participant Outcomes: Re-hospitalizations and VAD insertions 
Outcome                                                                                                                     N (%) 
Re-hospitalizations for HF from retained 21 participants                                  5 (23.80%) 
     Treatment of HF                                                                                            4 (80.00%) 
     Treatment for Dysrhythmias                                                                         1  (20.00%) 
     Treatment for non-HF diagnosis                                                                   1  (20.00%) 
VAD insertions, between T1 to T2, from original 21 participants                      1  (  4.76%) 
 VAD = Ventricular Assist Device 
 
The time to follow-up in the clinic for visit 2 from the hospitalization discharge 
ranged from 30 days to 123 days with a mean of 59.05 days (SD = 23.42) a median of 54 
days and a mode of 42, 48 and 68 days (2 participants each). The skewness was + 1.38 
and the kurtosis was + 1.97, demonstrating near symmetry and normalcy. The window 
for the follow-up was planned in the protocol to be 28 to 56 days in order to capture those 
participants who may have been re-hospitalized for HF within < 30 days. 
Some of the reasons for the time frame > 56 days included the fact that 
participants were re-hospitalized before T2, participants changed their appointment with 
their cardiologist to an earlier or later date, one participant was taken from the T2 visit to 
the hospital for re-hospitalization, thus preventing the T2 research visit, and VAD 
insertion between T1 and T2, thus prolonging the time for the follow-up visit with the 
cardiologist. Participants returning to the HF clinic to see their Cardiologist and to 
complete Visit 2 had various clinical complaints related to their HF status. 
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Upon return to the clinic, most participants had a slight improvement in their 
clinical symptoms of HF. However, because the sample was so small and the 
improvements in clinical symptoms were so slight, a significant difference could only be 
found in the clinical complaints of shortness of breath (SOB). Four (19%) continued to 
complain of shortness of breath (SOB), but that was a significantly smaller number of 
participants than complained of SOB on admission to the hospital (p = .02). Table 7 
details the lack of statistically different symptom complaints between the two visits. Six 
participants (28.6%) complained of water weight gain on admission to the hospital, but 
no one complained of water weight gain at T2 (n = 20), so a statistical difference could 
not be computed. It is worth noting that even though no one complained of water weight 
gain at T2, 60% of the 20 participants with weights at T2 did gain water weight (M: 7.07; 
range: 0.20 - 22 lbs. ).  
Table 7. Differences in Participants’ Clinical Complaints, Signs and Symptoms between 
    T1 and T2  
Clinical complaint,             T1                         T2              N          Pearson χ2          Fishers  
sign, or symptom                                                                          value               Exact test, 
                                                                                                                               2-sided 
SOB                           12 (57.1%)            4 (19.00%)      21            6.59                       .02 
DOE                           10 (47.6%)          11 (52.40%)     21            2.38                        .20 
Swelling/edema           9 (42.8%) 
Fatigue                         9 (42.9%) 
PND                             6 (28.6%)      
Ascites/bloating           3 (14.3%) 
Orthopnea                    2 (  9.5%)               
       1 (  4.76%)     21            1.40                        .14 
       9 (42.90%)     21            1.04                        .40 
       1 (  4.76%)     21              .42                      1.00 
       1 (  4.76%)     21            6.30                        .14 
       2 (  9.50%)     21            1.66                        .69 
 
 
Aim 1: Cognitive Impairment and Weight Change 
The primary aim of this study was to explore whether weight changes differed 
based on the presence or absence of cognitive impairment in HF participants who were 
followed in the clinic one to two months after discharge from the hospital for an acute 
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exacerbated HF admission. The Montreal Cognitive Assessment (MoCA) tool was used 
to establish baseline cognitive function at T1 enrollment into the study and the 
participants were weighed on dedicated research scales at T1 and in follow-up in the 
clinic at T2. The results of the data analysis will be discussed in order, beginning with the 
data analysis of the MoCA, then the weights on the research scales, and then the 
interaction of the data from these two variables. 
The Montreal Cognitive Assessment tool. 
The MoCA has a maximum score of 30. The scores on this tool at T1 ranged from 
15 to 29 with a mean of 24.10 and median of 24.00. The distribution of the MoCA scores 
was not symmetrical, being negatively skewed (-0.58). Since the measurement of kurtosis 
was +0.12, the MoCA scores are considered to have a close to normal peak and nearly 
normal distribution (Munro, 2005). In this sample, 42.9% (n = 21) of the participants 
scored < 24 at T1, which is evidence of cognitive impairment in adults with 
cardiovascular disease (Lee et al., 2013; Cameron et al., 2009). Low MoCA scores 
correlated with African American race (n = 4) (r = -.56, p = .01). High and low MoCA 
scores demonstrated a significant difference when examined with length of time 
diagnosed with HF at T1, t(df 19) = -2.33, p = .03.The educational level of the 
participants did not correlate with low or high MoCA scores (T1) (r = .41, p = .06). 
Gender, age, marital status, income, living status (married or single), and having a care 
provider in the home did not correlate with the MoCA score, either low or high. 
Change in Weight over time.  
 Participants were weighed on the research scales on the same day as enrollment. 
Due to delays in discharges, the enrollment weight was not the same as the discharge 
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weight in six cases as the participants either gained weight (0.3 and 1.6 lbs.) or lost 
additional weight (0.7 lbs. to 8.6 lbs.).  Other participants who were discharged within the 
planned 48 hours from enrollment, also gained or lost weight prior to discharge. The 
mean change in weight for the entire sample of 20 participants from enrollment to 
discharge was -2.4 lbs. (m = 193.41, SD 9.2; m = 1.91.02, SD 42. 44). However, the 
calculations for the variable of change in weight were made from the enrollment weight 
per study protocol. 
Participants were considered to have maintained their weight if their weight did 
not vary by more than ±2 lbs. of their weight upon enrollment into the study (T1) to the 
clinic visit (T2). If they gained or lost more than 2 lbs. then they were considered to have 
had a weight change. Table 8 shows the mean weights of the 20 study participants from 
the time they were enrolled in the research study at T1 to the time they were seen in the 
clinic at T2 with the mean change in their weight at T2. One of the final 21 participants 
did not want to get weighed on the research scales at T2. A paired T-test revealed there 
was no statistically significant difference in mean weights from T1 (M = 192.88, SD = 
43.24) to T2 (M = 192.45, SD 40.49), t(19) = .44, p = .84 (two-tailed). The mean change 
in weight was 0.43 (SD 9.64) with a 95% confidence interval ranging from -4.08 to 4.94. 
Table 8 Mean weights of the study participants at T1 and T2. N = 20 
 
                      Enrollment      Clinic F/U        Mean          Paired        95%                 P Value 
                  Research          Research          Change       T-Test       Confidence 
                  Scale                Scale                Score                            Interval  
Weight      192.88             192.45              0.43             t = .20      -4.08 to 4.94     p = .84  
 Lbs.          SD 43.24         SD 40.49         SD 9.63       df 19 
                  (n = 20)           (n = 20) 
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In this study, the range of weight lost to weight gained from enrollment at T1 to 
the Clinic Visit at T2 for 20 participants was -22.0 lbs. to 20.20 lbs. Fifty percent of the 
participants (n = 10) lost weight by T2, 10% (2 participants) maintained their weight 
(weight change 0.40 to -0.20), and 40% (n = 8) gained weight.   
Research Question 
1. Primary Research Question:  Is there a difference in weight change over 
time in those HF patients with and without cognitive impairment?  
In this study, participants were divided into three groups based on their change in 
weight: participants who lost more than two pounds by T2, participants who maintained 
weight between ± 2 lbs. of their T1 weight, and participant who gained more than two 
pounds by T2. An Independent T test was performed to examine the difference in weight 
change over time from enrollment at T1 to the clinic visit at T2 in HF patients with high 
and low scores on the MoCA at T1.  The mean change in weight for participants who 
scored higher on the MoCA (≥ 24) was +.62 lbs. (SD 11.22) while the mean change in 
weight for participants who scored lower on the MoCA (< 24) was +.20 lbs. (SD 7.94). 
There was no statistically significant difference between the change in weight on the 
research scales from T1 to T2 in those with high (M = .62, SD 11.22) or low MoCA 
scores (M = .20, SD 7.94; t(df 18) = -.09, p = .93) at T1.  
Aim 2: Cognitive Impairment and Functional Status, Depression, or NYHA Class  
A secondary aim was to explore whether functional status, depression, or NYHA 
Class in HF patients followed in the clinic one to two month after discharge from the 
hospital for an acute exacerbated HF admission differed according to baseline cognitive 
impairment. 
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Cognitive Function and Functional Assessments, T1 – T2. 
Activities of Daily Living. 
The Katz ADL and the Lawton IADL tools were used to assess functional status. 
All of these participants possessed basic, self-care skills at T1 as evidenced by the T1 
scores of 5 and 6 (Katz, et al., 1970).  The Instrumental Activities of Daily Living Scale 
(IADL) (Lawton & Brody, 1969) picked up on more deficits with self-care skills at 
enrollment. Out of a possible eight points, only 38.1% of the participants reported 
competence in every domain (M = 6.14, SD 1.88). The mean score for this sample at T2 
was 6.19 (SD 2.02). The change in IADL total scores from T1 to T2 was not statistically 
significant (p = .86). Table 9 shows the percentages of participants in each category.  
Table 9 Percentages of participants in each category of the IADL 
IADL items T1   N = 21 T2   N = 21 Paired T test 
 6.14 6.19 .86 
 21 (100.0%) 21 (100.0%)  
Shopping 
  Never Shop 
  Shops 
 
  8 (38.1%) 
13 (61.9%) 
 
  6 (28.6%) 
15 (71.4%) 
 
Food Prep 
  Never prepares food 
  Prepares food 
 
  9 (42.9%) 
12 (57.1%) 
 
10 (47.6%) 
11 (52.4%) 
 
Indoor or Outdoor House Keeping 
  Does neither housekeeping chores 
  Does either housekeeping chores 
   
4 (19.0%) 
17 (81.0%) 
 
15 (71.4%) 
  6 (28.6%) 
 
Laundry 
  Does no laundry 
  Does laundry 
 
  8 (28.1%) 
13 (61.9%) 
   
7 (33.3%) 
14 (66.7%) 
 
Mode of transportation 
  Must be taken everywhere 
  Can drive, take bus, etc. independently 
 
  5 (23.80%) 
16 (76.2%) 
   
3 (14.3%) 
18 (85.7%) 
 
Medication Responsibility 
  Is not independent with medications 
  Prepares and takes meds independently 
 
  3 (14.3%) 
18 (85.7%) 
 
  3 (14.3%) 
18 (85.7%) 
 
Finances 
  Is not independent with finances 
  Is independent with finances 
 
  2 (9.5%) 
19 (90.5%) 
 
  3 (14.3%) 
18 (85.7%) 
 
87 
Cognitive function and weight in HF patients 
A cross tabs was performed on IADL items at baseline to determine differences 
that were explained by gender Table 10 demonstrates that more men reported inability to 
shop (5 of 16 males vs. 1 of 5 females), prepare food (9 of 16 males vs. 1 of 5 females), 
and do laundry (6 of 16 males vs. 1 of 5 females). 
Table 10 Chi Square of significant gender differences in IADL’s 
IADL item Males, unable to 
perform 
Females, unable to 
perform 
Chi Square, Fisher’s 
Exact, Total 
Shopping 5 of 16 (31.25%) 1 of 5 (20%) .001 
Food Prep 9 of 16 (56.25%) 1 of 5 (20%) .002 
Laundry 6 of 16 (37.5%) 1 of 5 (20%) .003 
 
2. Secondary Research Question: Is there a difference in functional status, 
depression, or NYHA Class at follow-up in those HF patients with and 
without baseline cognitive impairment? 
Table 11 shows Paired T tests of differences between Katz ADL total scores at 
enrollment and at T2, as well as Lawton IADL total scores, BDI’s and MoCA total scores 
between T1 and T2. The paired sample differences were not significantly different for the 
Katz ADL, Lawton IADL’s, and the MoCA total scores between T1 and T2. The BDI 
scores were the only ones that showed a statistically significant difference in the BDI 
scores by the T2 clinic visit. 
Table 11 Differences in Mean scores of the main variables, T1 to T2 
Variables, 
Means 
Visit 1, mean score, 
±SD 
Visit 2, mean score, 
±SD 
Range 
of scores 
Paired 
Samples T 
test, Sig. (2 
tailed) 
Katz Score, M     5.76, SD ±   .44   5.86, SD ±   .48 0-6 .49 
Lawton Score, M     6.14, SD ± 1.88   6.19, SD ± 2.02 0-8 .86 
BDI Score, M   13.75, SD ± 8.47   9.65, SD ± 5.91 0-63 .01 
MoCA Score, M   24.10, SD ± 3.75 23.67, SD ± 4.94 0-30 .52 
Weights, M 192.88, SD ± 43.24 192.45, SD ± 40.49 N/A .43 
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An Independent T-test was performed to examine the difference between low and 
high MoCA scores at T1 and functional status at T2 as measured by the Katz ADL (p = 
.12) and Lawton’s IADL (p = .95), however, there was no statistically significant 
difference in this small sample. 
Cognitive Function and Depression Assessments, T1 – T2. 
 Beck Depression Inventory II. 
A Beck Depression Index-II (BDI-II) was used to assess depression in this 
population of HF participants. A score of 1-13 on the BDI-II correlates with minimal 
depression, while mild depression correlates with a score of 14-19 (Beck, et al., 1996; 
Beck, et al., 1961). A score of 20-28 correlates with moderate depression and a score of 
29-63 correlates with severe depression. In this population of participants, the BDI scores 
at enrollment ranged from 3 (9.5%) to 34 (4.8%) with a mean of 14.05 (SD 8.37), median 
of 13.00 and a mode of 13 (n = 4, 19.0%). In this population, 38.1% of the participants 
scored ≥ 14  on the BDI. The scores were skewed slightly to the right (.737), but 
represented nearly normal symmetry. The kurtosis score of .079 indicates nearly normal 
distribution. The left tail is thick due to the predominance of scores less than 20 resulting 
in the mean of only 14.05.  
Depression Assessment follow-up – Beck Depression Inventory II. 
The BDI-II was completed by 20 out of 21 participants at follow-up. One 
participant declined to fill out anymore forms due to extreme fatigue. Of the 20 who 
completed the BDI-II, the mean score was 9.65 (SD 5.90), with scores ranging from zero 
to 21, where scores < 14 indicate clinically insignificant depression and scores ≥ 14 
indicate mild (14 - 19), moderate (20 – 28), and severe (29 - 63) depression (Beck, et al., 
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1996; Beck, et al., 1961). In this population, 38.1% of the participants scored ≥ 14 on the 
BDI-II. The Skewness was .10 and the Kurtosis was -.87, indicating near normal 
symmetry and distribution. The Paired T-test for the mean BDI scores from T1 to T2 were 
significantly different (p = .01). Table 12 shows the percentages of participants with 
responses for each item between T1 and T2.  
Table 12: Percentages of participants with responses for each BDI item between 
    T1 and T2. 
BDI items T1 N = 21 T2 N = 20 Paired T Test 
Mean BDI scores 13.75 (SD 8.47) 9.65 (SD 5.91) .01 
Sadness 
  I do not feel sad 
  I feel sad much of the time 
 
 
14 (66.7%) 
  7 (33.3%) 
 
14 (70.0%) 
  6 (30.0%) 
 
Pessimism 
  I am not discouraged 
  I feel more discouraged  
 
 
  9 (42.9%) 
12 (57.2%) 
 
10 (50.0%) 
10 (50.0%) 
 
Past failure 
  I do not feel like a failure 
  I have failed more than I should 
have 
 
 
14 (66.7%) 
  7 (33.3%) 
 
15 (75.0%) 
  5 (25.0%) 
 
Loss of pleasure 
  I get as much pleasure as ever 
  I don’t enjoy things like I used to 
  I get very little (or no) pleasure 
 
 
  8 (38.1%) 
10 (47.6%) 
  3 (14.3%) 
 
  9 (45.0%) 
10 (50.0%) 
  1 (  5.0%) 
 
Guilty feelings 
  I don’t feel guilty 
  I feel guilty over many things 
 
 
18 (85.7%) 
  3 (14.3%) 
 
17 (85.0%) 
  3 (15.0%) 
 
Punishment feelings 
  I don’t feel I am being punished 
  I do feel I am being punished 
 
 
19 (90.5%) 
  2 (  9.5%) 
 
17 (85.0%) 
  3 (15.0%) 
 
Self-dislike 
  I feel the same about myself as ever 
  I have lost confidence in myself 
  I am disappointed in myself 
Table continues on next page 
 
13 (61.9%) 
  6 (28.6%) 
  2 (9.5%) 
 
17 (85.0%) 
  2 (10.0%) 
  1 (  5.0%) 
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BDI items T1 N = 21 T2 N = 20 Paired T Test 
Self-criticalness 
  I don’t criticize myself more than 
usual 
  I am more critical of myself than I 
used to be 
 
 
13 (61.9%) 
  6 (38.1%) 
 
12 (60.0%) 
  8 (40.0%) 
 
Suicidal thoughts 
  I don’t have thoughts of killing 
myself 
  I have thoughts of killing myself, 
but wouldn’t carry it out 
  I would like to kill myself 
 
 
18 (85.6%) 
 
  2 (  9.5%) 
 
  1 (  4.8%) 
 
20 (100.0%) 
 
  0 (    0.00%) 
 
  0 (    0.00%) 
 
Crying 
  I don’t cry any more than I used to 
  I cry more than I used to 
 
 
13 (61.9%) 
  8 (38,1%) 
 
16 (80.0%) 
  4 (20.0%) 
 
Agitation 
  I am no more restless than usual 
  I am more restless than usual 
 
 
10 (47.6%) 
11 (52.4%) 
 
15 (75.0%) 
  5 (25.0%) 
 
Loss of interest 
  I have not lost interest in people or 
activities 
I have lost interest in people or 
activities 
 
11 (52.4%) 
 
10 (47.6%) 
 
14 (70.0%) 
 
  6 (30.0%) 
 
    
Indecisiveness 
  I make decisions about as well as 
ever 
  It is more difficult to make decisions 
 
 
14 (66.7%) 
 
  7 (33.3%) 
 
17 (85.0%) 
 
  3 (  15.0%) 
 
Worthlessness 
  I do not feel I am worthless 
  I feel I am worthless 
 
 
15 (76.20%) 
  6 (28.60%) 
 
17 (85.0%) 
  3 (15.0%) 
 
Loss of energy 
  I have as much energy as ever 
  I have less energy than I used to 
  I don’t have enough energy to do 
very much 
Table continues on next page 
 
 
  0 (  0.00%) 
13 (61.9%) 
  8 (38.1%) 
 
  5 (25.0%) 
13 (65.0%) 
  2 (10.0%) 
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BDI items T1 N = 21 T2 N = 20 Paired T Test 
Sleep Patterns 
  I have not experienced any change  
  I sleep somewhat more or less than 
usual 
  I sleep a lot more or a lot less than 
usual 
 
 
  3 (14.3 %) 
13 (61.9%) 
 
  5 (23.80%) 
 
  5 (25.0%) 
10 (50.0%) 
 
  5 (25.0%) 
 
Irritability 
  I am no more irritable than usual 
  I am more irritable than usual 
 
 
13 (61.9%) 
  8 (38.1%) 
 
14 (70.0%) 
  6 (30.0%) 
 
Appetite 
  I have not experienced any change 
in my appetite 
  My appetite is somewhat more or 
less than usual 
  My appetite is much more or less 
than usual 
 
 
  3 (14.3%) 
 
12 (57.1%) 
 
  6 (28.6%) 
 
  6 (30.0%) 
 
  7 (35.0%) 
 
  7 (35.0%) 
 
Concentration 
  I can concentrate as well as ever 
  I can’t concentrate as well as usual 
 
 
  8 (38.1%) 
13 (57.9%) 
 
13 (65.0%) 
  7 (35.0%) 
 
Fatigue 
  I am no more tired than usual 
  I get more tired than usual 
  I am too tired to do what I like to do 
 
 
  4 (19.0%) 
  9 (42.9%) 
  8 (38.1%) 
 
  7 (35.0%) 
  9 (45.0%) 
  4 (20.0%) 
 
Sex 
  My interest in sex has not changed 
  I am less interested in sex than I 
used to 
 
  7 (33.3%) 
14 (66.7%) 
 
10 (50.0%) 
10 (50.0%) 
 
 
Research Question: Is there a difference between low and high MoCA scores at 
T1 with scores on the BDI-II at T2? 
An Independent T-test was used to examine the difference between low (n = 9, M 
= 6.22, SD 2.33) and high (n = 12, M = 6.17, SD 1.85) MoCA scores at T1 and 
depression at T2 as measured by the BDI-II; t(df 19) = .06, p = .95. There was no 
statistically significant difference.  
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Research Question: Do MoCA scores at T1 correlate with NYHA Class at T1 and 
T2? 
The MoCA score at T1 correlated inversely with the NYHA Classification at both T1 
(r= -.53, p = .01) and T2 (r = - 0.50, p =.02).  
Aim 3: Cognitive impairment or weight change and diuretic dose adjustments 
The third aim of this study was to explore whether there was a difference in 
weight or baseline cognitive function in HF participants who received a high number or 
low number of diuretic dose adjustments one to two months after discharge from the 
hospital for an acute exacerbated HF admission. 
Diuretic Dose Adjustments and Weight. 
Diuretic dose adjustments by the nurses managing outpatient care included 
changing the dose of furosemide or Bumex for up to three days, adding metolazone for 
up to three days, or switching from furosemide to Bumex. The number of different 
diuretics that a participant could have been on may have been as much as three 
(furosemide, Bumex, and Metolazone) not counting spironolactone/eplerenone. Of the 
total sample, 42.9% (n = 9) required no diuretic dose adjustments, leaving 57.1% needing 
dose adjustments. Of those who had a diuretic dose adjustment (12 participants), 41.7% 
(n = 5) required only one adjustment, 58.3% (7) required two to 11 dose adjustments. 
Tertiary Research Question: Is there a difference in weight change over time in 
those HF patients who have a low number versus a high number of diuretic dose 
adjustments when followed in the clinic one to two months after discharge from the 
hospital for an acute exacerbated HF admission? 
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To examine whether there a difference in weight change over time in those HF 
patients who had one to 11 diuretic dose adjustments, the number of adjustments was 
divided into two categories, a low number of dose adjustments (1 adjustment) and a high 
number of dose adjustments (2 – 11). Twelve of the 21 participants in this sample 
required adjusting their diuretic. Of these 12, five participants (41.7%) had one 
adjustment in their diuretic dosing during the period from T1 to T2. Seven of the 12 
participants (58.3%) had two to 11 adjustments to their diuretic during this period. An 
Independent T test showed no statistically significant difference in weight change over 
time between a low number of diuretic dose adjustments (M = -7.36, SD 9.13) and a high 
number of diuretic dose adjustments (M = 1.71, SD 7.36); t (df 10) = -1.91, p = .09 (two-
tailed).   
Research Question: Is there a difference in baseline cognitive status in those HF 
patients who had a low number of diuretic dose adjustments versus a high number of 
diuretic dose adjustments when followed in clinic one to two months after discharge? 
An Independent T test was performed to determine if there was a difference in 
baseline cognitive status in those HF participants who had a low number of diuretic dose 
adjustments (0 to 2) versus a high number of diuretic dose adjustments (3 - 11) by T2. 
There was no statistically significant difference in high and low MoCA scores from 
baseline (M = 24.29, SD 3.55) in participants who had 2 or fewer diuretic dose 
adjustments compared to participants who had 3 ,6, or 11 diuretic dose adjustments (M = 
23.25, SD 5.06); t(df 19) = .49, p = .63 (two-tailed). 
Additional Findings 
Characteristics of fluid management by these participants. 
94 
Cognitive function and weight in HF patients 
Participants were queried at T1 and T2 regarding a fluid restriction prescription, 
whether they followed the prescription and whether they weighed themselves daily.  
Seventy-five percent of these participants knew they had been prescribed a fluid 
restriction and that number increased by T2 to 85%. At T1, only 1/3 of participants knew 
the amount of the fluid restriction, but by T2, 82.3% of the participants new that their 
restriction was 64 ounces. At T1, only 23.80% of the participants (n = 5/21) always 
followed their restriction and 15% said they never weighed themselves. By T2, nearly 
half (46.7%) reported following the fluid restriction daily, but a Chi Square demonstrated 
that it was not statistically significant in this small sample (p = .61).  Nearly half of the 
participants weighed themselves daily at T1, and this number increased to 85.7% by T2 
and no one reported never weighing themselves.  
Clinician reported Neurological and cognitive assessment.  
This study documented that cognitive function was not measured or documented 
in this sample of patients at time of admission to the hospital by the healthcare providers. 
The minimal assessment for orientation was not performed on every patient (n = 20) 
during T1 (95.2%) and consisted only of documenting  that they were awake, alert, and 
oriented times three on admission (AAOx3). There was no assessment tool to measure 
orientation other than the ability to state one’s name, where they were, and the date.  
Only 33.3% of the participants (n = 21) were documented as being able to move all 
extremities (MAE’s), while it was not even mentioned on the other 66.7% of these 
patients. Muscle strength received a comment on four of these 21 patients (19.0%). Mood 
and affect was not documented on 71.4% of patients (n = 21) and sensorium/sensation 
was not mentioned on 71.4% of the patients. Many of the patients in this group (52.4%) 
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had their cranial nerves II – XII described as being “intact” and reflexes were not 
mentioned in 95.2% of these patients. The ability to follow commands was not mentioned 
in 90.5% of these patients. Three patients (14.3%) had their neurological exam described 
as “grossly non-focal” and the status of memory was not mentioned in 71.4%. Eight of 
these patients were noted to have normal judgment and insight.  
Neurological Assessment at follow-up. 
 All participants were documented as being “Awake, Alert, and Oriented (AAO).” 
The fact that they “Move All Extremities” was recorded on three (14.3%). “Normal 
muscle strength” and “normal sensorium” were recorded on four participants (19% on 
each). Five participants were documented to have their “Cranial Nerves II-XII” to be 
intact and six to have “normal mood/affect.”  “Normal reflexes” and “the ability to follow 
commands” were not mentioned for any of the 21 participants. Ten of the participants 
were recorded as being “grossly non-focal” and five were documented has having 
“memory intact.” Beyond that, there were no reported tools for measuring cognitive 
function. 
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Chapter 5: Discussion, Conclusions, Recommendations 
Overview of Study  
 The purpose of this study was to examine whether weight changes differed based 
on the presence or absence of cognitive impairment in HF participants who were 
followed in the clinic one to two months after discharge from the hospital after an 
exacerbation of HF.  Additionally, this study sought to explore whether diuretic dose 
adjustments influenced weight change from T1 (enrollment in the hospital) to T2 during a 
regularly scheduled clinic visit. Results of this study provide greater understanding of the 
occurrence of mild cognitive impairment in Class II to IV HF patients admitted to the 
hospital for acute exacerbation of HF and the relationship of diuretic dose adjustments to 
change in weight in the first one to two months after discharge.  In this small sample, 
42.9 % of participants at enrollment had MoCA scores < 24, indicating cognitive 
impairment. However, there was no difference in weight change from enrollment to 
follow-up based on presence or absence of cognitive impairment or the number of times 
the diuretic dose was adjusted post-discharge.   
Discussion 
Primary Aim: Cognitive Function and Weight Changes. 
The Montreal Cognitive Assessment Tool (MoCA) was used to measure the 
following domains of cognitive function: Memory, Executive Function, Visuospatial 
abilities, Language, Mental Speed and Attention and were assessed using the Montreal 
Cognitive Assessment Tool (Nasreddine et al., 2005). In this study, 42.9% of the subjects 
scored ≤ the cutpoint of 24 on the MoCA.  Lee et al. (2013) reported a cut point of 24 on 
the MoCA for participants with cardiovascular disease is a more sensitive measure for 
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identifying reductions in self-care agency than the previously published cutpoint of 26 for 
the general population (Nassredine et al., 2005). Our finding is consistent with previously 
published reports of cognitive impairment in HF patients using various assessment tools 
between 22% to 70% (Pressler et al., 2010; Vogels, Oosterman, van Harten, Scheltens, et 
al., 2007). Research was reported in which 14.2% of Class II-IV HF patients had mild 
cognitive impairment (Lee et al., 2013). Sixty-six percent of 75 patients with systolic 
dysfunction in another study demonstrated found cognitive impairment (Bauer & Pozehl, 
2010). The MoCA was used for screening in HF outpatients ≥ 65 years of age in which 
70% scored <26 (Harkness, Demers, Heckman & Mckelvie, 2011). Four screening 
measures of cognition were tested in 42 patients with HF, which reported that cognitive 
impairment was detected in 12 (28.6%) of the participants (Riegel, Bennett, et al., 2002).  
Vogels, Oosterman, Van Harten, Gouw, et al., (2007) found that 25% of HF patients 
showed more problems with executive function, memory, language, mental speed and 
attention compared to healthy controls. 
Furthermore, HF patients with cognitive impairment may be at risk for self-care 
deficits. One of the most important components of a patient’s ability to care for oneself is 
having the cognitive function to learn about the medical therapies, to understand them, 
and to implement them (Woo et al., 2009; Wu, Moser, Lennie, & Burkhart, 2008; 
Zuccalà, et al., 2005). Treatment for acute exacerbated HF is focused on maximizing 
cardiac function through the use of multiple medications including diuretics 
(Gheorghiade, Shah, et al., 2013; Mosel & Riegel, 2004). The method for measuring the 
success of diuresis is daily weights done by the patient in their home (Mosel & Riegel, 
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2004). The ability of the patients to remember to take their medications and weigh 
themselves daily requires intact cognitive function (Woo et al., 2009).   
Weights. 
In this small sample, there was no clear tendency for the group of patients to 
either gain or lose weight. At follow-up, there was no documentation in the Medical 
Record of the participants complaining of water weight gain even though 40 % did gain 
0.4 to 20.20 lbs., which was suggestive of water weight gain. Fifty percent of the 
participants lost weight, 10% did not change their weight, and 40% of the participants 
gained weight.  It illustrates, if anything, that weight fluctuations in HF patients are 
varied with a multifactorial causality related to medical and nursing management, patient 
unique characteristics, and the nature of the disease process in which a patient may gain 
fluid weight or become cachectic due to deteriorating disease process. 
Almost half (n = 9, 42.9%) of the T2 visits did not happen within the four to eight 
week window. The five participants who were re-hospitalized were seen after discharge 
from the second hospitalization. The remaining four participants who were seen outside 
of the window changed their clinic appointments to an earlier or later date than 
scheduled, so were missed and had to be seen for the T2 visit at a later visit.  As a result 
of these variations in the timing of the T2 clinic visit, the resulting weights could be 
higher, lower, or the same as if the T2 visit had been completed during the window.   
Cognitive Function and Change in Weight from T1 to T2. 
Findings demonstrated that there was no statistically significant difference in 
weight change over time with low or high scores on the Montreal Cognitive Assessment 
tool at T1 (MoCA). The mean change in weight for participants who scored higher on the 
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MoCA (≥ 24) was + 0.62 lbs. while the mean change in weight for participants who 
scored lower on the MoCA (< 24) was +.20, which was not statistically significant.  This 
surprising finding is difficult to explain, but there are several possible factors that may be 
considered. The first is that the sample size was so small as to prevent the sampling of a 
wide variety of HF patients who may have demonstrated weight gain at T2, especially if 
they had cognitive impairment. Another reason has to do with the use of data from 
enrollment rather than from discharge. An additional factor is that patients who declined 
to enroll in the study may have been the ones to demonstrate more cognitive impairment 
at enrollment and/or more weight gain over time. A fourth factor may be that patients 
who have more serious deterioration of their cardiac function may fail to eat well due to 
reduced appetite and become nutritionally depleted due to this failure coupled with 
reduced GI malabsorption thus developing cardiac cachexia (von Haehling, Lainscak, 
Springer, & Anker, 2009). This failure to maintain a healthy nutritional status may mask 
the insidious development of fluid accumulation. Finally, medical and nursing 
management of advanced stage HF patients is focused on maximizing cardiac function 
resulting in discovering, treating and mitigating weight gain early in its trajectory, 
thereby preventing patients from having excessive weight gain (Yancy et al., 2013). 
Secondary Aim: Cognitive Function, Functional Status, Depression, and 
 NYHA Classification. 
A secondary aim was to explore whether functional status, depression, or NYHA 
Class in HF patients followed in the clinic one to two month after discharge from the 
hospital for an acute exacerbated HF admission differed according to baseline cognitive 
impairment.  Previous research has shown that there is a correlation between cognitive 
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function and functional scores, depression, and NYHA class (Alosco et al., 2012; Faller 
et al., 2009; Heo et al., 2014; Katz, S., 1983, McLennan et al., 2010; Nabi et al., 2010; 
Tousoulis et al., 2010).  
Two tools were used to analyze functional status, the Katz ADL and the Lawton 
Instrumental Activities of Daily Living Scale (IADL) screening tools. The Katz ADL 
documented that all of these participants possessed basic, self-care skills at T1 as 
evidenced by the scores of 5 and 6 out of a maximum of 6 (Katz, et al., 1970).  Since 
42.9% of the participants in this study scored below 24 on the MoCA, one would expect 
to see lower scores on the Katz ADL in order to be more in line with international 
statistics (Mutai, Furukawa, Araki, Misawa, & Hanihara, 2012). Mutai et al. (2012), 
found that in 174 stroke patients (mean age 73.0 ± 10.8; 51.12% male), cognitive 
functional independence measured at admission (22.4 ± 8.3) was a statistically significant 
predictor of functional recovery by discharge (OR = 1.12; 95% CI 1.03 – 1.22; p < .001).  
The IADL (Lawton & Brody, 1969) picked up on more deficits with self-care 
skills at enrollment into this study. Out of a possible eight points, only 38.1% of the 
participants reported competence in every domain. Another research team had similar 
findings, in which their population of HF patients (n = 122) completed a 
neuropsychological battery including the Mini-Mental State Examination and Trail 
Making Tests A & B, the Lawton IADL along with a 2-minute step test to estimate 
fitness, (Alosco et al., 2012) They found that scores were high on basic ADL skills, but 
the IADL scores showed that 37.7% needed assistance with laundry (p = <.001), 34.4% 
with housekeeping (p < .05), and 31.1% with food preparation (p < .05) (Alosco et al., 
2012).  
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At follow-up at T2, items on the IADL in which differences were noted were 
Mode of Transportation, in which two of 16 males and one of five females reported had 
lost their independence. Medication Responsibility, in which three of 16 males and zero 
females reported dependency, and Finances, in which two of 16 males and one of five 
females reported losing their independence also demonstrated lower IADL scores. 
Independence in Mode of Transportation and being in charge of finances may have 
importance for both genders across the life span. The change in IADL total scores from 
T1 to T2 was statistically insignificant (p = .86). In this study, there was no statistically 
significant difference between low and high MoCA scores at T1 and functional status at 
T2 as measured by the Katz Activities of Daily Living (ADL) and Lawton’s Index of 
Activities of Daily Living (IADL). There was a statistically significant difference 
between males and females on certain activities of daily living as measured by the 
Lawton IADL such as laundry, cooking, and housekeeping measures. 
More men reported inability to shop (5 of 16 males vs. 1 of 5 females), prepare 
food (9 of 16 males vs. 1 of 5 females), and do laundry (6 of 16 males vs. 1 of 5 females). 
The extent to which IADL items varied by gender was based on culturally derived norms, 
several decades of depending on wives to do chores that the husbands never did in the 
first place. Eight participants (38.1%) reported needing help with shopping, or that their 
wives routinely did the shopping. Nine (42.9%) reported that they needed help with food 
preparation or that their wives routinely did all the food preparation so they really did not 
know how to in her absence. Four participants (19.0%) reported that they needed help 
with or never did any housekeeping.  Cultural norms for these activities need to be 
considered before assigning significance to these responses, although keeping house 
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included outdoor work such as mowing the lawn, which several men said they could no 
longer do.  The maximum score was 8 with 8 considered to be high functioning for 
women and 5 considered to be high functioning for men due to the fact that culturally 
speaking, most men do not do food preparation, housekeeping and laundering even if 
they are able (Graf, 2007). 
Cognitive Function and Depression.  
The impact of MoCA scores on the difference in BDI-II scores between T1 and T2 
was also examined.  Depression in the cardiovascular population has been variously 
reported to be between 10% (de Jonge et al., 2006) to 42% (Rutledge et al., 2006). In this 
sample, 28.6% had a history of depression documented in the medical record on 
admission to the hospital, yet 14.3% of the sample scored between 14-19 and 24% of the 
sample had a score of ≥ 20 on the BDI upon enrollment into the study. Collectively, 
therefore, 38.3% of the sample had mild, moderate, or severe depression at T1, so this 
cohort of participants were representative of other HF patients in the United States (US) 
(Go, et al., 2014; Orgen et al., 2014).  
There was no statistically significant difference (p = .95) between low and high 
MoCA scores at T1 and depression at T2. One participant was too tired to do the BDI at 
T2, so only 20 pairs were examined. There is a difference of the occurrence of depression 
between that documented in the medical record and that elicited by patient report through 
the BDI-II of their feelings of depression by six percentage points. Therefore, eight of 
these 21 participants needed to be further screened for depression associated with their 
admission to the hospital for acute exacerbated HF. While most people in this sample did 
not have thoughts of suicide (85.7%) at T1, one person from the sample circled the item 
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“I would like to kill myself.” This result was not reported to the PI as this issue was 
already known to the PI.  
Of note, the BDI-II scores improved between T1 and T2. At follow-up, these 
participants reported problems with energy, fatigue, and altered sleep patterns, as would 
be expected with HF patients (Go, et al., 2014; Lee et al., 2013, Ogren et al., 2014). The 
mean results of the BDI-II tool at T2 (9.65, SD ± 5.91) did not support the presence of 
depression generally in this HF population.  Published studies have found that depression 
interferes with patients’ abilities to engage in self-care. Both the Katz and Lawton mean 
scores were compared to the BDI-II at T2, but in this small highly functional sample and 
a mean BDI-II score of 9.65, there was not enough depression to demonstrate an impact 
on functional status.  
Cognitive function and New York Heart Class. 
The correlation between cognitive function as measured by the MoCA screening 
tool and New York Heart Class was examined. A moderate statistically significant 
inverse relationship was observed between MoCA scores at T1 and NYHA at T1 and 
MoCA at T1 and NYHA at T2, even though the NYHA classifications had improved 
across the group of participants by T2. This finding is consistent with other studies which 
demonstrated that as NYHA class increases, cognitive function decreases (Go, et al., 
2014, Orgen et al., 2014). Additionally, it was found that the MoCA scores were lower 
for participants with higher NYHA class. This finding is similar to national statistics 
(Yancy et al., 2013). However, the impact of MoCA scores at T1 on the difference in the 
mean BDI-II scores between T1 and T2 was not statistically significant. 
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Tertiary Aim: Diuretic Dose Adjustments, Weight Change, and Cognitive  
Function.  
The third aim of this study was to explore whether there was a difference in 
weight or baseline cognitive function in HF participants who received a high number or 
low number of diuretic dose adjustments one to two months after discharge from the 
hospital for an acute exacerbated HF admission. Diuretic dose adjustments after 
discharge included changing the dose of furosemide or Bumex or adding metolazone. 
The number of diuretic dose adjustments ranged from zero for nine participants to 11 for 
one participant. Other dose or diuretic adjustments were one adjustment for five 
participants, two adjustments for three participants, three adjustments for two participants 
and six diuretic dose adjustments for one participant. There was no statistically 
significant difference in weight change over time between a low number of diuretic dose 
adjustments and a high number of diuretic dose adjustments (p = .09) although it was 
approaching statistical significance and deserves to be restudied with a larger sample.  
Possible explanations for this finding include that participants who had nearly stable 
weights needed less diuretic dose adjustments and those who received more diuretic dose 
adjustments achieved a more stable weight. Additionally, the sample size was too small 
to demonstrate any measurable trends on these variables. There was no statistically 
significant difference in MoCA scores from baseline in participants who had 2 or fewer 
diuretic dose adjustments compared to participants who had 3, 6, or 11 diuretic dose 
adjustments. The importance of this concept rests with the thought that if a HF patient is 
fluid overloaded, the cardiac performance worsens, possibly reducing cerebral perfusion 
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pressure resulting in reduced cognitive function. However, the findings in this study did 
not support that, possibly due to the low numbers of participants in this study.  
Additional Findings 
Heart Failure. 
 Since emergency room visits and repeat hospitalizations for HF cost up to $44 
billion per year (Shah, et al, 2013; Gheorghiade, Vaduganathan, et al., 2013), it would be 
important to manage these physiologic relationships at home and prevent hospital 
readmissions. In this study, 23.80% of the participants were readmitted to the hospital 
within 30 days for treatment of acute exacerbated HF, which is similar to national 
statistics (Go et al, 2014; Gheorghiade, Vaduganathan, et al., 2013).  
These participants received evidenced based care compared to national statistics. 
The number of patients on Milrinone, either at home or in the hospital was 28.6%, which 
is similar to standard of care in the US (Go et al., 2014).  Eighteen (85.7%)  participants 
had Automatic Implantable Cardioverter Defibrillators and 42.9% had BiV pacers (or 
CRT-D’s). The latest statistics from the National Cardiovascular Data Registry’s ICD 
Registry document that 80.35% to 84.02% of 107,096 patients nationwide had CRT-D’s 
implanted from 2006-2010 (Eapen et al., 2012). The American Heart Association (AHA) 
guidelines for the management of HF estimate that only about 30% of Class III-IV HF 
patients probably meet the criteria of widening QRS morphology to qualify for placement 
of a CRT-D device (Yancy et al., 2013), but Eapen et al. (2012) note that individual 
circumstances may influence a physician to place CRT-D’s in patients who do not meet 
these rigid guidelines, such as some Class II patients. 
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Characteristics of fluid management.  
Participants were queried at T1 and T2 regarding a fluid restriction prescription, 
whether they followed the prescription and whether they weighed themselves daily.  
Seventy-five percent of these participants knew they had been prescribed a fluid 
restriction and that number increased by T2 to 85%. At T1, only 1/3 of participants knew 
the amount of the fluid restriction, but by T2, 82.3% of the participants new that their 
restriction was 64 ounces. At T1, only 23.80% of the participants always followed their 
restriction and 15% said they never weighed themselves. By T2, nearly half reported 
following the fluid restriction daily.   
Nearly half of the participants weighed themselves daily at T1, and this number 
increased to 85.7% by T2 and no one reported never weighing themselves. Although there 
was an increase in the percentage of participants who reported that they followed the 
Fluid Restriction every day at enrollment versus at T2, it was not statistically significant 
in this small sample (p = .56). The fact that more participants knew that they had a fluid 
restriction, knew the amount, followed the restriction, and weighed themselves by T2 is a 
testament to the educational efforts of the nurses caring for these participants.  
These findings are similar to other studies. Data from 648 hospitalized HF 
patients demonstrated that at baseline, adherence to fluid restriction was 72% and 
improved to 89% after receiving educational support over 18 months, while adherence to 
daily weighing was 34% and improved to 85% after receiving educational support over 
18 months (Nieuwenhuis, Jaarsma, Van Veldhuisen, Postmus, & Van der Wal, 2012). 
The “Get with the Guidelines-Heart Failure” registry studied data collected from 236 
American hospitals and 54,322 patients from 2005 – 2007 (36 months of data) 
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(Ambardekar et al., 2009). They found that 2.4% of these patients had dietary non-
adherence and an additional 2.35% of patients had both medication and dietary non-
adherence. They also found that among their non-adherent patients, there was greater 
volume overload as evidenced by higher body weight than the adherent group (p > 
.0001), increased jugular venous distention (p > .0001), crackles in the lung fields (p > 
.0001), lower extremity edema (p > ,0001), and higher brain natriuretic peptide levels (p 
> .0001).  
Neurological and Cognitive Assessments by Health Care Providers 
Finally, this study documented that cognitive function was not documented in this 
sample at time of admission to the hospital by the health care providers even though 
42.9% of the participants demonstrated cognitive impairment by scoring < 24 on the 
MoCA. This study also documented that neurological assessments were performed 
erratically and that little to no cognitive assessments were done beyond asking for 
orientation to person, place, and time.  
The fact that these participants scored well on the Orientation section, calls into 
question the common practice of assuming that assessing patients for orientation is an 
adequate assessment of cognitive status. Of these participants 95.2% were documented as 
being awake, alert, and oriented times three on admission (AAOx3). There was no 
standard tool to measure orientation other than the ability to state one’s name, where they 
were, and the date.   
Neurological assessments at the follow-up visit were equally sparse. All 
participants were documented as being “Awake, Alert, and Oriented (AAO).” Beyond 
that, there were no tools for measuring cognitive function. These data are similar to that 
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reported by Dodson et al. (2013) and Pressler et al (2010). Dodson et al. (2013) studied 
282 in-patient HF patients (M = 80 years) using the Folstein Mini-Mental State 
Examination. They found that 46.8% had some degree of cognitive impairment (CI) 
(mild 25.2%, 21.6% moderate-severe) but only 22.7% had CI documented by the 
physicians. Those whose impairment was less severe (median MMSE of 22.0 vs 18.0, p < 
.01) tended to be the ones not documented. In addition, those whose CI was not 
documented were significantly more likely to experience 6-month mortality or hospital 
readmission than patients without CI (adjusted HR 1.53; 95% CI, 1.06-2.20; p = .02) 
(Dodson et al., 2013). This study supports these results and lays the foundation for 
developing an argument for dedicated assessments of patients’ cognitive function 
separate from a neurological assessment. 
Cognitive Impairment 
No one was enrolled in this study who had a previous diagnosis of dementia or 
required a personal caregiver to assist with Activities of Daily Living (ADL’s). This 
study documented that 42.9% of the participants scored < 24 on the MoCA tool, which 
raised the question of whether these individuals had previously undiagnosed cognitive 
impairment. Cognitive impairment is increasingly recognized as being associated with 
HF (Dodson, et al., 2013; Ogren, Fonarow, & Woo, 2014; Pressler, et al., 2010; Wolfe, 
Worrall-Carter, Foister, Keks, and Howe, 2006) and occurs on a continuum between 
normal cognitive function and total cognitive disability/dementia. There is evidence of 
diminished cognitive skills which may include short term memory and attention 
disorders, and problems with organizing and problem solving which impair patients’ 
abilities to implement a treatment regime that includes fluid and water restriction ( Lee et 
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al., 2013:Pressler et al., 2010). Because the sample is so small, it is not statistically sound 
to do a sub-analysis of the various parts of the MoCA to isolate the particular sub-tests 
that contributed to the low scores. Therefore, the scores of < 24 identify participants who 
may need further cognitive evaluation to characterize functional deficits.  
Conclusions 
Patients with HF may have cognitive impairment which could impact self care 
management. Cognitive impairment (CI) was documented in 42.9% of this sample and 
the data also shows that the MoCA scores were lower for participants with higher NYHA 
Class.  While there was no difference between CI and weight change or diuretic dose 
adjustment, this could be due to the small sample size, and warrants further exploration in 
other studies. In this study, 23.8% of this small sample were readmitted to the hospital for 
treatment of acute exacerbated HF, which is very similar to the national average of 20% 
readmission rate (Go et al., 2014). Additionally, four of the five participants who were 
rehospitalized had cognitive impairment. 
 Statistically significant differences found in this study were a decrease in the 
BDI-II scores between T1 and T2, and a significant difference between males and females 
on certain activities of daily living as measured by the Lawton IADL. Other findings 
included that there was no statistically significant difference between MoCA scores at T1 
and functional status scores and depression scores between T1 and T2 in this small sample 
of relatively high functioning participants. Due to the small sample size, the extent of 
impact of any of the findings is not able to be calculated. 
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Significance to Nursing Practice 
This study is significant to nursing practice because it documents a need to 
incorporate cognitive function assessments into the discharge planning process to better 
provide needed services to HF patients at home. A patient’s ability to maintain their 
weight depends on having the cognitive skills to take their medications as prescribed, to 
follow a fluid restriction, and to weigh themselves daily. They must be able to analyze 
the significance of variations in their weight and engage in a problem solving process to 
determine the appropriate action to take when they determine that the weight variation is 
indicative of fluid overload; and then to make that phone call to their cardiologist or to 
take the prn diuretic.  
When CI is documented, then patients are unable to actively engage in these self 
care behaviors independently. They are unable to translate the discharge teaching 
materials from the hospital into the home environment without assistance. The family 
members may not realize that their loved one has these deficits and may be ill prepared to 
fill the void.  They may be surprised when their loved one does not follow the fluid 
restriction, does not do daily weights and argues with them when confronted about their 
nonadherence. 
A patient’s ability to manage their weight is directly linked with maintaining 
euvolemia and maximal cardiac output. Failure to follow a prescribed fluid management 
program and performance of daily weights can destabilize a patient clinically leading to 
exacerbation of HF symptoms and increasing frequency of hospital readmissions, 
(Howlett, 2011; Hunt et al., 2009; Parrinello et al., 2008). Maintaining euvolemic weight 
is a cornerstone of HF care (Moser & Riegel, 2004). It is imperative that current nursing 
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practice in the management of HF patients must change. Nurses should perform cognitive 
screenings on patients with Class II-IV HF in order to better plan for their discharge 
needs. 
Recently, researchers have focused on the association between cognitive 
impairment and HF (Go et al., 2014, Lee et al., 2013, Ogren et al., 2014; Pressler et al., 
2010; Vogels, Oosterman, Van Harten, Gouw, et al., 2007). These findings show the 
relationship between cognitive impairment and blunted responses to HF symptoms (Lee 
et al., 2013) or that executive dysfunction predicts mortality and morbidity at one year 
(Pressler et al., 2010). HF experts recommend systematic assessment of cognitive 
function in HF patients (Cameron et al., 2009; Yancy et al., 2013). However, no research 
was found on the relationship between cognitive impairment and change in weight in HF 
patients. 
Strategies for post discharge contact with heart failure patients. 
While there are many studies and recommendations for discharge programs for 
HF patients, there are no studies to date which highlight the unique needs of cognitively 
impaired HF patients. There are programs at some health care practices that contact 
patients after discharge to assess them for dyspnea, fatigue, and lower extremity edema, 
as well as requesting a report of daily weights, blood pressures, and knowledge of 
medications (Parrinello et al., 2013). Miller and Schaper (2015) also reported the use of 
telephone follow-up calls to reduce readmission rates. Telemonitoring is being used more 
often to monitor HF patients at home, capturing data on weight, blood pressure, and heart 
rate (Blum & Gottlieb, 2014). The role of the nurse navigator to reduce rehospitalization 
is being described in the literature to provide education, ensure accurate medication 
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reconciliation, to assist the patient with making follow-up appointments and facilitate 
communications with other care providers (Schell, 2014). Other strategies include 
reducing caregiver burden and use of cardiac rehabilitation (McClintock, Mose, and 
Smith, 2014). None of these articles addressed the needs of the cognitively impaired HF 
patient. Nurse-led outpatient heart failure clinics have a proven track record of reduction 
of all-cause mortality and should flourish in the health care system (Bdeir et al., 2015).  
Strategies for discharge transitions. 
An alternative to current practice is to first identify HF patients with mild 
cognitive impairment and assess the home environment for suitability for discharge to 
home.  A unique transition care model was studied in Australia called Transition Care: 
Cognitive Assessment and Management Pilot (TC CAMP) because it was recognized that 
people with cognitive impairment require more time and support beyond the walls of the 
hospital to optimize their functional capacity in order to reduce hospital readmissions 
(Renehan, Haralambous, Galvin, Kotis, and Dow, 2013). Among the underpinnings of 
this program was the understanding that persons with cognitive impairment can become 
disoriented to time and place resulting in behavioral disruptions. Additionally, persons 
with cognitive impairment experience memory lapses and cannot remember what they 
were taught in the hospital (Lee et al., 2013; Pressler, et al., 2010). Using a person and 
family-centered approach, the staff included a nurse specialist who was the liaison with 
families, performed cognitive assessments, behavior management and discharge 
planning. Additionally, there were a geriatrician, occupational therapist and other allied 
health as required.  
113 
Cognitive function and weight in HF patients 
Once identified as having cognitive impairment, hospitalized HF patients need 
more support in transitioning to home.  Similar to the TC CAMP model mentioned 
above, but not involving transitioning to a residential facility, patients with cognitive 
impairment need to have a home visiting nurse (HVN) every day, not just 2-3 days per 
week, along with ancillary personnel to help with ADL’s as indicated. The first home 
visit should include a home assessment as well as making sure that the weighing scales 
are available on a hard flat surface, a patient-usable method of keeping track of fluid 
consumption is available to the patient, that high sodium foods are identified for disposal, 
and that the medications are reconciled and easily available to the patient in a pill 
dispenser among many other safety concerns for a home visiting nurse to assess. The first 
visit should include not only a physical assessment, but re-education about meds, fluids, 
and diet along with an easily readable chart for medication names, doses, and schedule. 
These daily visits need to continue until the HVN signs off on the patient.  The TC 
CAMP model above had 60 day renewable options for care (Renehan, et al,, 2013), so 
should home care. Home care is likely to be less expensive even with daily HVN visits, 
and certainly less expensive that multiple HF re-hospitalizations. 
Nurses need to teach patients and families about the possibilities of cognitive 
impairment with HF so that they can better plan for their future. Additionally, patients 
need to be able to plan for their day to day safety in order to carry out all of the therapies 
prescribed for them for the management of their HF. Healthcare providers teach patients 
a lot of information about their disease processes and expect them to go home and begin 
to implement everything they learned. But if a patient has injury to the Executive 
Function area of their brain, they are not able to plan, organize, and sequence well 
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enough to carry out all the therapies prescribed.  Healthcare providers teach HF patient 
not to drink more than 64 ounces of fluid per day, but if their Executive Function area of 
the brain is injured, then they cannot do math.  Accusations of non-compliance are 
useless characterizations in this scenario. Nurses need to know when their patients have 
mild cognitive impairment in order to be better teachers for our patients and families as 
well as better discharge planners. 
Limitations of Study  
There were a variety of limitations to the study that have to do with sample size; 
setting; personal characteristics of the patients who were willing to be in the study versus 
those who refused; type of HF, natural course of HF over time; fluid management self-
report tool; and the cognitive, functional, and depression assessment tools. The main 
limitation of the study was the small sample size. As a result, there were not enough 
participants to do reliable statistical analysis. Efforts to increase the sample size included 
modifying the protocol to add a third cardiologist whose practice specialized in HF 
patients at the same academic medical center and adding a third clinic to accommodate 
that practice. This addition did improve enrollment numbers, but only slightly. Because 
of the small sample size, statistical significance on most measures could not be achieved 
and on those measures that were statistically significant, the sample was too small to 
achieve statistical power.  Of concern when doing clinical research is the unjustifiable 
research burden on participants enrolled in a study that is underpowered (Munro, 2005). 
However, when doing novel research such as this one, unanticipated barriers may arise 
that confound one’s ability to enroll the numbers required for statistical power. There is 
an argument to be made that for novel research, a smaller N may be acceptable in order to 
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investigate the feasibility and scientific justification for investigating the topic (Bacchetti, 
Deeks, & McCune, 2011; Sauro, 2013). 
 Recruiting participants from a single medical center resulted in a homogenous 
sample of patients, mostly male, and mostly Caucasian, thus limiting generalizability of 
the findings. The study needed to be expanded to include other academic centers to not 
only increase the sample size, but to also broaden the variety of patients enrolled and to 
incorporate a wider variety of cardiology practices. 
The participants who were willing to be in the study may have been more 
comfortable with filling out questionnaires and not have been intimidated by the fact that 
one of them was a screening tool for cognition. The study is only applicable to patients 
with systolic HF and left ventricular ejection fraction (LVEF) ≤ 40%. The LVEF was 
measured as much as 12 months prior to enrollment in the study, which is a limitation, 
however, it was only used to document the presence of left ventricular impairment.  
Management of patients with HF is very complex. An inaccurate, simplistic 
understanding of outpatient management of patients with HF is that they gain weight in 
Class IV HF as their myocardium deteriorates. In actuality, some patients gain weight, 
but some patients become cachectic due to loss of appetite mediated by reduced blood 
flow to the GI tract and malabsorption of nutrients among other factors. As a result they 
lose weight, while still demonstrating physical signs of fluid overload. 
The patient who needed the most diuretic dose adjustments (11) scored 29/30 on 
the MoCA, 8/8 on the Lawton IADL, and still gained 6.8 lbs.  Another patient who 
scored 27/30 on the MoCA gained 20 lbs. and somehow received no diuretic dose 
adjustments, while demonstrating a Lawton IADL score of 3/8. The patient who lost 22 
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lbs. scored only 24/30 on the MoCA, 5/8 on the Lawton IADL (normal for a male) and 
only had 1 diuretic dose adjustment.  These three examples are provided here to illustrate 
that in this small sample, outliers skewed the expectations that highly functional patients 
with a higher cognitive score would need fewer diuretic dose adjustments while still 
being able to maintain one’s study enrollment weight. This study is not able to 
demonstrate that higher cognitive scores impact on self-care, assuming that no change in 
weight is a surrogate for self-care. What is not known is whether any of these patients 
who lost weight were seasoned patients who knew when to call the HF nurse for diuretic 
dose adjustments. Additionally, the patients may have not understood the importance of 
following their fluid restriction prior to their baseline hospitalization, indeed some denied 
knowing that they were on a fluid restriction.  However, due to the hospitalization and 
teaching by the nurses both during the hospitalization and afterward, they became more 
aware of the need to follow a fluid restriction. It is not possible in this study to distinguish 
whether a change in behavior due to education by the nurses or any possible 
improvement in cognitive performance resulted in less weight gain in the overall sample. 
Additionally, some participants with Class IV HF scored very high on the MoCA, 
while other Class IV patients scored low and vice versa. A larger sample size may have 
resulted in a more reliable distribution of the MoCA scores with less deviation around the 
mean.  The MoCA tool is in itself a limitation, as it is merely a screening tool. The results 
do not necessarily indicate that someone does or does not have cognitive impairment, but 
merely that someone needs to be further evaluated.  Additionally, some potential 
participants may have been intimidated by the fact that the study involved a thinking 
skills questionnaire and thus declined to participate. 
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The fluid restriction self-report is fraught with limitations due to the problems 
with patients recalling accurately if they drink no more than the number of ounces per 
day prescribed by their health care provider and weigh themselves daily. Furthermore, 
their routine may vary from day to day and their ability to remember whether they do or 
do not follow the fluid restriction may be limited in the presence of cognitive impairment. 
Emotionally, they may want to please the researcher or appear desirable, as well as 
experience the emotional trauma of admitting that they do not follow these prescriptions. 
So they may report what they think the researcher wants to hear. Documentation of a 
written prescription for a fluid restriction by the physician or nurse practitioner was 
fragmented. 
The IADL is difficult to analyze as it measures functioning in areas such as 
cooking and housekeeping which may be culturally determined (Graf, 2007). Both 
fatigue and depression have a negative effect on one’s ability to perform IADL’s, 
however this study was not able to demonstrate that depression changed the IADL scores 
between T1 and T2. 
The Beck Depression Inventory II measures several somatic complaints, such as 
fatigue, appetite, and interest in sex. Low scores on these measures may falsely indicate 
depression in a HF patient, when, in fact, the patient has these symptoms due to their HF 
pathophysiology (Ogren et al., 2014). 
Recommendations for Future Research 
There are many areas of future research. First, this study needs to be modified and 
repeated in order to reach statistical significance so as to add to the beginning evidence of 
cognitive impairment in patients with HF. It definitely needs to be done, since there are 
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still no studies examining the impact of cognitive impairment on change in weight. One 
way to modify the study would be to involve more academic medical centers and more 
staff so as to enroll the required number of participants within one year.  
In the outpatient setting, there needs to be more research on the value and role of 
nurse-led clinics while even expanding the role of these clinics to include biometric 
measurements and outpatient administration of intravenous Lasix if indicated.  Other 
research needs to be done on transitions of care from hospital to home.  It is possible to 
increase the amount of assistance in the home environment for HF patients with cognitive 
impairment in order to prevent the more expensive hospital readmissions.  
Another area for potential research is to examine the state of practice of nurses as 
well as physicians in doing cognitive assessments. The US Preventative Task Force 
(Moyer, 2014) recommends that there is no significant value to doing routine cognitive 
screening on older Americans. The key word here is “routine.” There is an imperative to 
screen high risk individuals and the data needs to be developed to demonstrate that 
cognitive screening is not being done and whether Americans have worse outcomes when 
no screening is done to support discharge planning. 
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Appendix A 
 
Katz Index of Independence in Activities of Daily Living 
 
Activities 
Points (1 or 0) 
Independence:  
(1 point) 
No supervision, direction or 
personal assistance 
Dependence: 
(0 points) 
With supervision, direction, personal 
assistance or total care 
Bathing 
 
       Points_________ 
 
(1 Point) Bathes self completely 
or needs help in bathing only a 
single part of the body such as 
the back, genital area or disabled 
extremity 
(0 Points) Needs help with bathing 
more than one part of the body, getting 
in or out of the tub or shower. Requires 
total bathing. 
Dressing 
 
       Points_________ 
 
(1 Point) Gets clothes from 
closets and drawers and puts on 
clothes and outer garments 
complete with fasteners. May 
have help tying shoes. 
(0 Points) Needs help with dressing 
self or needs to be completely dressed. 
Toileting 
 
       Points_________ 
 
(1 Point) Goes to toilet, gets on 
and off, arranges clothes, cleans 
genital area without help. 
(0 Points) Needs help transferring to 
the toilet, cleaning self or uses bedpan 
or commode 
Transferring 
 
       Points_________ 
 
(1 Point) Moves in and out of 
bed or chair unassisted. 
Mechanical transferring aides are 
acceptable. 
(0 Points) Needs help in moving from 
bed to chair or requires a complete 
transfer. 
Continence 
 
       Points_________ 
 
(1 Point) Exercises complete self 
control over urination and 
defecation. 
(0 Points) Is partially or totally 
incontinent of bowel or bladder. 
Feeding 
 
       Points_________ 
 
(1 Point) Gets food from plate 
into mouth without help.  
Preparation of food may be done 
by another person. 
(0 Points) Needs partial or total help 
with feeding or requires parenteral 
feeding. 
 
 
 
 
 
Slightly adapted from Katz, S., Down, T. D., Cash, H. R. & Grotz, R. C. (1970). Progress in the 
development of the index of ADL. The Gerontologist, 10(1), 20-30. 
Copyright © The Gerontological Socety of America. Reproduced [Adapted] by permission of the publisher  
 
 
 
 
 
Total Points = ____________ 6 = High (patient independent)    0 = low (patient very dependent) 
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Appendix B 
INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE (IADL) 
M.P. Lawton & E.M. Brody 
A. Ability to use telephone 
1. Operates telephone on own initiative; looks up and dials numbers, etc.  1 
2. Dials a few well-known numbers       1 
3. Answers telephone but does not dial      1 
4. Does not use telephone at all.       0 
 
B. Shopping 
1. Takes care of all shopping needs independently     1 
2. Shops independently for small purchases      0 
3. Needs to be accompanied on any shopping trip.     0 
4. Completely unable to shop.       0 
 
C. Food Preparation 
1. Plans, prepares and serves adequate meals independently    1 
2. Prepares adequate meals if supplied with ingredients    0 
3. Heats, serves, prepares meals or prepares meals but does not maintain adequate diet. 0 
4. Needs to have meals prepared and served.      0 
 
D. Housekeeping 
1. Maintains house alone or with assistance (e.g. “heavy work domestic help”)  1 
2. Performs light daily tasks such as dishwashing, bed making    1 
3. Performs light daily tasks but cannot maintain acceptable level of cleanliness.  1 
4. Needs help with all home maintenance tasks.     1 
5. Does not participate in any housekeeping tasks.     0 
 
E. Laundry 
1. Does personal laundry completely      1 
2. Launders small items; rinses stockings, etc.     1 
3. All laundry must be done by others.      0 
 
F. Mode of Transportation 
1. Travels independently on public transportation or drives own car.   1 
2. Arranges own travel via taxi, but does not otherwise use public transportation.  1 
3. Travels on public transportation when accompanied by another.   1 
4. Travel limited to taxi or automobile with assistance of another.   0 
5. Does not travel at all.        0 
 
G. Responsibility for own medications 
1. Is responsible for taking medication in correct dosages at correct time.  1 
2. Takes responsibility if medication is prepared in advance in separate dosage.  0 
3. Is not capable of dispensing own medication.     0 
 
H. Ability to Handle Finances 
1. Manages financial matters independently (budgets, writes checks, pays rent, bills goes to 
bank), collects and keeps track of income.      1 
2. Manages day-to-day purchases, but needs help with banking, major purchases, etc. 1 
3. Incapable of handling money.       0 
 
Source: Lawton, M.P., and Brody, E.M. “Assessment of older people: Self-maintaining and instrumental 
activities of daily living.” Gerontologist 9:179-186, (1969). 
Copyright (c) The Gerontological Society of America. Used by permission of the Publisher. 
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Montreal Cognitive Assessment (MoCA) 
Instructions 
 
MoCA Version August 18, 2010    © Z. Nasreddine MD 
www.mocatest.org 
 
Administration and Scoring Instructions 
 
The Montreal Cognitive Assessment (MoCA) was designed as a rapid screening 
instrument for mild cognitive dysfunction. It assesses different cognitive domains: 
attention and concentration, executive functions, memory, language, visuoconstructional 
skills, conceptual thinking, calculations, and orientation. Time to administer the MoCA is 
approximately 10 minutes. The total possible score is 30 points; a score of 26 or above is 
considered normal. 
 
1. Alternating Trail Making: 
 
Administration: The examiner instructs the subject: "Please draw a line, going from a 
number to a letter in ascending order. Begin here [point to (1)] and draw a line from 
1 then to A then to 2 and so on. End here [point to (E)]." 
 
Scoring: Allocate one point if the subject successfully draws the following pattern: 
1 −A- 2- B- 3- C- 4- D- 5- E, without drawing any lines that cross. Any error that is 
not immediately self-corrected earns a score of 0. 
 
2. Visuoconstructional Skills (Cube): 
 
Administration: The examiner gives the following instructions, pointing to the cube: 
“Copy this drawing as accurately as you can, in the space below”. 
 
Scoring: One point is allocated for a correctly executed drawing. 
• Drawing must be three-dimensional 
• All lines are drawn 
• No line is added 
• Lines are relatively parallel and their length is similar (rectangular prisms are 
accepted) 
A point is not assigned if any of the above-criteria are not met. 
 
3. Visuoconstructional Skills (Clock): 
 
Administration: Indicate the right third of the space and give the following 
instructions: “Draw a clock. Put in all the numbers and set the time to 10 past 11”. 
 
Scoring: One point is allocated for each of the following three criteria: 
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• Contour (1 pt.): the clock face must be a circle with only minor distortion 
acceptable (e.g., slight imperfection on closing the circle); 
• Numbers (1 pt.): all clock numbers must be present with no additional numbers; 
numbers must be in the correct order and placed in the approximate quadrants on 
the clock face; Roman numerals are acceptable; numbers can be placed outside 
the circle contour; 
• Hands (1 pt.): there must be two hands jointly indicating the correct time; the 
hour hand must be clearly shorter than the minute hand; hands must be centred 
within the clock face with their junction close to the clock centre. 
 
A point is not assigned for a given element if any of the above-criteria are not 
met. 
 
4. Naming: 
 
Administration: Beginning on the left, point to each figure and say: “Tell me the 
name of this animal”. 
 
Scoring: One point each is given for the following responses: (1) lion (2) rhinoceros 
or rhino (3) camel or dromedary. 
 
5. Memory: 
 
Administration: The examiner reads a list of 5 words at a rate of one per second, 
giving the following instructions: “This is a memory test. I am going to read a list of 
words that you will have to remember now and later on. Listen carefully. When I am 
through, tell me as many words as you can remember. It doesn’t matter in what order 
you say them”. 
Mark a check in the allocated space for each word the subject produces on this first 
trial. When the subject indicates that (s)he has finished (has recalled all words), or can 
recall no more words, read the list a second time with the following instructions: “I 
am going to read the same list for a second time. Try to remember and tell me as 
many words as you can, including words you said the first time.” Put a check in the 
allocated space for each word the subject recalls after the second trial. 
 
At the end of the second trial, inform the subject that (s)he will be asked to recall 
these words again by saying, “I will ask you to recall those words again at the end of 
the test.” 
 
Scoring: No points are given for Trials One and Two. 
 
6. Attention: 
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Forward Digit Span: Administration: Give the following instruction: “I am going 
to say some numbers and when I am through, repeat them to me exactly as I said 
them”. Read the five number sequence at a rate of one digit per second. 
 
Backward Digit Span: Administration: Give the following instruction: “Now I am 
going to say some more numbers, but when I am through you must repeat them to 
me in the backwards order.” Read the three number sequence at a rate of one digit 
per second. 
 
Scoring: Allocate one point for each sequence correctly repeated, (N.B.: the 
correct response for the backwards trial is 2-4-7). 
 
Vigilance: Administration: The examiner reads the list of letters at a rate of one 
per second, after giving the following instruction: “I am going to read a sequence 
of letters. Every time I say the letter A, tap your hand once. If I say a different 
letter, do not tap your hand”. 
 
Scoring: Give one point if there is zero to one errors (an error is a tap on a wrong 
letter or a failure to tap on letter A). 
 
Serial 7s: Administration: The examiner gives the following instruction: “Now, I 
will ask you to count by subtracting seven from 100, and then, keep subtracting 
seven from your answer until I tell you to stop.” Give this instruction twice if 
necessary. 
 
Scoring: This item is scored out of 3 points. Give no (0) points for no correct 
subtractions, 1 point for one correction subtraction, 2 points for two-to-three 
correct subtractions, and 3 points if the participant successfully makes four or five 
correct subtractions. Count each correct subtraction of 7 beginning at 100. Each 
subtraction is evaluated independently; that is, if the participant responds with an 
incorrect number but continues to correctly subtract 7 from it, give a point for 
each correct subtraction. For example, a participant may respond “92 – 85 – 78 – 
71 – 64” where the “92” is incorrect, but all subsequent numbers are subtracted 
correctly. This is one error and the item would be given a score of 3. 
 
7. Sentence repetition: 
 
Administration: The examiner gives the following instructions: “I am going to 
read you a sentence. Repeat it after me, exactly as I say it [pause]: I only know 
that John is the one to help today.” Following the response, say: “Now I am 
going to read you another sentence. Repeat it after me, exactly as I say it [pause]: 
The cat always hid under the couch when dogs were in the room.” 
 
Scoring: Allocate 1 point for each sentence correctly repeated. Repetition must be 
exact. Be alert for errors that are omissions (e.g., omitting "only", "always") and 
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substitutions/additions (e.g., "John is the one who helped today;" substituting 
"hides" for "hid", altering plurals, etc.). 
 
8. Verbal fluency: 
Administration: The examiner gives the following instruction: “Tell me as many 
words as you can think of that begin with a certain letter of the alphabet that I 
will tell you in a moment. You can say any kind of word you want, except for 
proper nouns (like Bob or Boston), numbers, or words that begin with the same 
sound but have a different suffix, for example, love, lover, loving. I will tell you to 
stop after one minute. Are you ready? [Pause] Now, tell me as many words as you 
can think of that begin with the letter F. [time for 60 sec]. Stop.” 
 
Scoring: Allocate one point if the subject generates 11 words or more in 60 sec. 
Record the subject’s response in the bottom or side margins. 
 
9. Abstraction: 
 
Administration: The examiner asks the subject to explain what each pair of words 
has in common, starting with the example: “Tell me how an orange and a banana 
are alike”. If the subject answers in a concrete manner, then say only one 
additional time: “Tell me another way in which those items are alike”. If the 
subject does not give the appropriate response (fruit), say, “Yes, and they are also 
both fruit.” Do not give any additional instructions or clarification. After the 
practice trial, say: “Now, tell me how a train and a bicycle are alike”. Following 
the response, administer the second trial, saying: “Now tell me how a ruler and a 
watch are alike”. Do not give any additional instructions or prompts. 
 
Scoring: Only the last two item pairs are scored. Give 1 point to each item pair 
correctly answered. The following responses are acceptable:  
Train-bicycle = means of transportation, means of travelling, you take 
trips in both; 
Ruler-watch = measuring instruments, used to measure. 
The following responses are not acceptable:  
Train-bicycle = they have wheels; Rulerwatch = they have 
numbers. 
 
10. Delayed recall: 
 
Administration: The examiner gives the following instruction: “I read some 
words to you earlier, which I asked you to remember. Tell me as many of those 
words as you can remember.” Make a check mark ( √ ) for each of the words 
correctly recalled spontaneously without any cues, in the allocated space. 
 
Scoring: Allocate 1 point for each word recalled freely without any cues. 
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Optional: 
Following the delayed free recall trial, prompt the subject with the semantic 
category cue provided below for any word not recalled. Make a check mark 
( √ ) in the allocated space if the subject remembered the word with the 
help of a category or multiple-choice cue. Prompt all non-recalled words in 
this manner. If the subject does not recall the word after the category cue, 
give him/her a multiple choice trial, using the following example 
instruction, “Which of the following words do you think it was, NOSE, 
FACE, or HAND?” 
 
Use the following category and/or multiple-choice cues for each word, 
when appropriate: 
FACE: category cue: part of the body multiple choice: nose, face, hand 
 
VELVET: category cue: type of fabric multiple choice: denim, cotton,  
velvet 
CHURCH: category cue: type of building multiple choice: church, school, 
hospital 
DAISY: category cue: type of flower multiple choice: rose, daisy, tulip 
RED: category cue: a colour multiple choice: red, blue, green 
 
Scoring: No points are allocated for words recalled with a cue. A cue is 
used for clinical information purposes only and can give the test 
interpreter additional information about the type of memory disorder. For 
memory deficits due to retrieval failures, performance can be improved 
with a cue. For memory deficits due to encoding failures, performance 
does not improve with a cue. 
11. Orientation: 
 
Administration: The examiner gives the following instructions: “Tell me the date 
today”. If the subject does not give a complete answer, then prompt accordingly 
by saying: “Tell me the [year, month, exact date, and day of the week].” Then 
say: “Now, tell me the name of this place, and which city it is in.” 
 
Scoring: Give one point for each item correctly answered. The subject must tell 
the exact date and the exact place (name of hospital, clinic, office). No points are 
allocated if subject makes an error of one day for the day and date. 
 
TOTAL SCORE: Sum all subscores listed on the right-hand side. Add one point for 
an individual who has 12 years or fewer of formal education, for a possible maximum 
of 30 points. 
A final total score of 26 and above is considered normal. 
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Appendix E 
Fluid Management 
Did your doctor or nurse practitioner prescribe a fluid restriction for you?    Yes     No 
Do you follow the fluid restriction?  Always     Sometimes     Never     Uncertain 
Do you weigh yourself daily?           Always     Sometimes     Never     Uncertain 
How much is the fluid restriction?_____________________________ 
How much fluid do you think you drink per day?____________________ 
Describe how you keep track of how much fluid you have consumed and how much  
fluid can still be consumed for the rest of the day. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________ 
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Appendix F 
Taylor Body fat Scales-Biggest Loser 7544bl Cal-max by Taylor Wide Body Scale, 
440-Pound capability 
 
• Extra wide 15 inch platform  
• Weighs to 440 lbs/200kgs  
• Cal-max indicates maximum calories you can consume to maintain weight  
• 5 year warranty  
Counting calories has never been easier! cal-max calculates your minimum calorie intake 
to maintain your current weight. eat fewer calories, start losing weight. super wide 15 
inch tempered glass platform for extra comfort, large 2.2 inch display with 2 inch lcd 
digits and extremely high capacity of 440 lb / 200 kg in 0.2 lb / 0.1 kg increments. scale 
uses 1 long life lithium battery (included) 5 year warranty. 
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